Promotion of physical activity in Parkinson's disease - the challenge to change behavior - by Nimwegen, M.L. van
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/105821
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
promotion of
in parkinson's disease
physical activity
MARLIES VAN NIMWEGEN
THE CHALLENGE TO CHANGE BEHAVIOR
 The research presented in this thesis was supported by and carried out at the department of Neurology of the 
Nijmegen Centre of Evidence Based Practice of the Radboud University Nijmegen Medical Centre.
 The research was further supported by grants from the Netherlands Organization for Health Research and 
Development (ZonMw), the Michael J Fox Foundation for Parkinson’s research. Additional (financial) support 
was provided by VGZ (health insurance company); Glaxo Smith Kline; Philips Consumer Lifestyle (DirectLife); and 
National Parkinson Foundation.
 Printing and dissemination of this thesis was financially supported by the Radboud University Nijmegen Medical 
Centre, Novartis Pharma BV, Stichting Alkemade-Keuls, UCB Pharma BV, Stichting GlaxoSmithKline BV, Parkinson 
Vereniging, Ipsen Farmaceutica BV.
 Promotion of physical activity in Parkinson’s disease feasibility and effectiveness Thesis, 
 Radboud University Nijmegen, the Netherlands 
 Design: IS=Ontwerp • Ilse Schrauwers • www.isontwerp.nl 
 Cover concept and movement-illustrations: Nynke Hester Bakker 
 Printing: Ipskamp Drukkers B.V. • www.ipskampdrukkers.nl 
 ISBN: 978-94-6191-598-6
 © Marlies van Nimwegen
 No part of this thesis may be reproduced or transmitted in any form or by any means,electronic or mechanical, 
including photocopy, recording or otherwise without permission of the author.
PROMOTION OF 
PHYSICAL ACTIVITY 
IN PARKINSON'S DISEASE
the challenge to change behavior
 
Proefschrift
ter verkrijging van de graad van doctor 
aan de Radboud Universiteit Nijmegen
op gezag van de rector magnificus prof. mr. S.C.J.J Kortmann,
volgens besluit van het college van decanen
in het  openbaar te verdedigen op woensdag 6 maart 2013
om 13.30 uur precies
door
Maria Louise van Nimwegen
geboren op 29 januari 1982
te Apeldoorn
PROMOTOREN
 Prof. dr. B.R. Bloem
 Prof. dr. G.F. Borm
COPROMOTOREN
 Dr. M. Munneke
 Dr. S. Overeem
MANUSCRIPTCOMMISSIE
 Prof. dr. R. Nijhuis-van der Sanden (voorzitter)
 Prof. dr. J.J. van Hilten (LUMC)
 Prof. dr. M. Hopman-Rock (VUmc)
 There are two primary choices in life; 
to accept conditions as they exist, 
or accept the responsibility for changing them. 
Denis Waitley
promotion of physical activity in parkinson's disease • the challenge to change behavior
6 7
contents
CHAPTER 01 PAGE 09 PAGE 89
PAGE 103
PAGE 111
PAGE 123
PAGE 131
PAGE 139
PAGE 137
PAGE 157
PAGE 159
PAGE 161
PAGE 19
PAGE 33
PAGE 49
PAGE 59
PAGE 73
CHAPTER 07
CHAPTER 02
CHAPTER 08
CHAPTER 03
CHAPTER 09
CHAPTER 04
CHAPTER 10
CHAPTER 05
CHAPTER 11
CHAPTER 12
CHAPTER 06
INTRODUCTION & AIMS OF THIS THESIS EVALUATION OF IMPLEMENTATION OF THE PARKFIT PROGRAM: 
A MULTIFACETED INTERVENTION AIMED TO PROMOTE PHYSICAL 
ACTIVITY IN PATIENTS WITH PARKINSON’S DISEASE
Submitted PHYSICAL INACTIVITY IN PARKINSON’S DISEASE
Journal of Neurology – 2011; 258 (12), 2214-21
SUMMARY 
DESIGN AND BASELINE CHARACTERISTICS OF THE PARKFIT STUDY, 
A RANDOMIZED CONTROLLED TRIAL EVALUATING THE EFFECTIVENESS 
OF A MULTIFACETED BEHAVIORAL PROGRAM TO INCREASE PHYSICAL 
ACTIVITY IN PARKINSON PATIENTS 
BMC Neurology – 2010; 10:70
GENERAL DISCUSSION & FUTURE PERSPECTIVES
MULTIVARIABLE ANALYSES OFTEN HAVE MULTIPLE SOLUTIONS, 
ALL OF WHICH SHOULD BE REPORTED 
Submitted 
NEDERLANDSE SAMENVATTING
QUANTIFYING DAILY PHYSICAL ACTIVITY AND ITS DETERMINANTS IN
SELF-REPORTED SEDENTARY PARKINSON’S DISEASE PATIENTS
Submitted 
DANKWOORD
12.1 REFERENCES
12.2  LIST OF PUBLICATIONS
12.3  CURRICULUM VITAE
12.4  DISSERTATIONS OF THE PARKINSON CENTRE NIJMEGEN (PARC)
PROMOTION OF PHYSICAL ACTIVITY AND FITNESS IN SEDENTARY PATIENTS 
WITH PARKINSON’S DISEASE, A RANDOMIZED CONTROLLED TRIAL
British Medical Journal – 2012; in press
CONTENTS
01GENERAL INTRODUCTION 
& AIMS OF
THIS THESIS
CHAPTER
10 11
promotion of physical activity in parkinson's disease • the challenge to change behavior introduction & aims of this thesis 0101
PARKINSON’S DISEASE
 Parkinson’s disease (PD) is one of the most common neurodegenerative diseases. The preva-
lence is estimated at around 1.3% to 1.5% for people above the age of 60 years.1 Ageing is 
a major risk factor for PD; due to the growing elderly population, the prevalence will increase 
sharply in the next decades. 
 PD is characterized by motor symptoms including bradykinesia, tremor, rigidity, gait disturbances 
and postural instability.2 In addition to these symptoms, a wide variety of non-motor symptoms 
like depression or apathy is present in almost all patients; examples include autonomic dysfunc-
tion, depression, fatigue, cognitive decline, and sleep disturbances.3 All these symptoms mar-
kedly impair the quality of life, and with disease progression, most patients experience severe 
disability. People with PD carry a relatively heavy illness burden compared with those suffering 
from other chronic conditions: only people with high spinal cord injury (among the conditions 
leading to physical impairments) and people with depression (among the conditions leading to 
mental impairments) scored lower on quality of life.4 
 The underlying causes of PD are still largely unknown, but the changes in the brain and resulting 
pathophysiology are becoming quite clear. It is widely appreciated that dopaminergic neurons 
from the pars compacta of the substantia nigra degenerate progressively, resulting in a moun-
ting central dopamine deficiency in various dopaminergic circuitries. Levodopa, combined with 
a peripheral dopa decarboxylase inhibitor (benserazide or carbidopa), can correct this dopa-
mine deficiency and remains to date the most effective therapy.5 An increasing number of other 
dopaminergic drugs is also available to alleviate the symptoms of PD. For a selected subgroup 
of patients, deep brain surgery is a therapeutic option. 
 As the disease progresses, non-dopaminergic brain areas become progressively involved in 
the neurodegenerative process. This leads to emergence of debilitating symptoms and signs 
that fail to respond adequately to dopamine replacement therapy or deep brain surgery. In 
addition to the medical management approaches, allied health interventions and specialized 
Parkinson nurses are increasingly deployed to treat both the dopaminergic and non-dopami-
nergic symptoms of PD. The evidence to support the merits of these interventions is gradually 
growing and treatment guidelines (partially based on evidence, partially on practical clinical ex-
perience) for some of these allied healthcare interventions have been developed6-8: for example, 
the use of physiotherapy is described in Textbox 1. Integrating all various treatment options into 
a bundled multidisciplinary approach (along with pharmacological and surgical treatment) is 
widely felt to represent an optimal therapeutic strategy for this complex, multifaceted disease.9 10
12 13
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PHYSICAL ACTIVITY AS A MEDICINE? 
 Although medical treatment with levodopa substantially improves the quality of life and func-
tional capacity, PD remains an incurable disease that results in considerable and progressive 
disability for almost all affected patients. Therefore, new and better treatment approaches are 
needed to suppress the symptoms and signs of PD, and to perhaps slow down or even arrest the 
otherwise relentless disease progression. This thesis examines whether promotion of physical 
activities could represent such an intervention. 
 There are several reasons to assume why more physical activity might be benefi cial for PD pa-
tients. First, physical activity could have potential disease-specifi c effects, for example by impro-
ving cognitive dysfunction and mood.22-24 Second, recent studies have shown that exercise can 
have a benefi cial effect on the neurodegenerative process in rodent models of PD. Specifi cally, 
studies in rats and mice with experimental parkinsonism indicate that exercise can prevent and 
decelerate the development of experimental parkinsonism through several mechanisms that 
involve neural plasticity of the dopaminergic and glutamatergic system.25-28 Of course, extrapo-
lation of these experimental fi ndings to patients requires extreme caution. However, the results 
have fuelled speculation that exercise might perhaps be used to modify the course of PD by 
acting directly on the neurodegenerative process. Taken together, these symptomatic and presu-
med disease-modifying effects raise hope that exercise could be used as a ‘medicine’ in patients 
with PD. Exercise as a medicine, it sounds both easy and simple, but it is not, as we shall see in 
this thesis. 
 Sedentary behavior is a major public health problem and it is one of the highest risk factors 
for death in developed countries.29 Changing a sedentary lifestyle is diffi cult, even for healthy 
people; and to increase physical activity in old persons or in patients with one or multiple chro-
nic conditions is even harder. This is particularly true for PD patients who typically experience 
a combination of both physical limitations and mental changes, which creates considerable 
barriers to become physically active. A critical question that is addressed in this thesis is whether 
people with PD can achieve an enduring increase in their physical activities in daily life. And 
even when such a sustained change in lifestyle is possible, it needs to be demonstrated whether 
this change can improve disease-specifi c symptoms and prevent development of co-morbid 
complications. 
* In the Netherlands, the content of the evidence-based guideline for physiotherapy in PD is identical to the guidelines  for 
Cesar exercise therapists and Mensendieck exercise therapists. Therefore, the term ‘physiotherapy’ also includes Cesar and 
Mensendieck exercise therapies.
TEXTBOX 1
PHYSIOTHERAPY IN PD*
 Even with optimal medical treatment, patients with PD experience a decline of body function and mobility. This can 
lead to inactivity and social isolation, resulting in a reduced quality of life. To reduce these motor impairments, 
physiotherapy can be effective.11 The evidence-based guideline for physiotherapy in PD describes specifi c treatment 
areas.11 The objective of physiotherapy is to improve the patient’s independence, safety and well-being. 
 In the Netherlands, specialized physiotherapy for patients with PD - as well as other healthcare professions such 
as speech & language therapy or occupational therapy - is available in regional professional networks, known as 
ParkinsonNet.12 13 Each ParkinsonNet network consists of a small number of healthcare professionals who have 
been specifi cally trained to treat PD patients according to evidence-based recommendations. To further improve 
the quality of care, ParkinsonNet aims to improve the accuracy of referrals by neurologists, and to increase the 
patient volume per therapist. Moreover, collaboration and communication between the participating health pro-
fessionals is stimulated.12 A large cluster-controlled trial has shown that the ParkinsonNet concept achieves these 
goals, and also leads to a substantial cost reduction that may be as high as 1400 Euros per patient per year.13
BENEFITS OF PHYSICAL ACTIVITY
 Living an active lifestyle promotes health. The benefi ts of regular physical activity are exten-
sive14-16: being physically active increases survival,17 18 and it prevents people from chronic disea-
ses such as cardiovascular disease, diabetes, cancer, hypertension, obesity, depression and 
osteoporosis.14 Moreover, physical activity may improve specifi c symptoms such as sleep impair-
ment, depression, and constipation.19 Several biological mechanisms may be responsible for the 
benefi ts associated with physical activity: for example, habitual physical activity has been shown 
to improve vascular function and cholesterol levels, to reduce blood pressure and body weight, 
to prevent bone loss associated with aging, and to increase cardiac function. Because of the 
benefi ts associated with physical activity and exercise, international guidelines state that every 
adult “should accumulate 30 minutes or more of moderate-intensity physical activity on most, 
preferably all, days of the week’’.20 21 There are no reasons to assume that similar health benefi ts 
will not apply to chronic patients as well.
14 15
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such hazardous activities, and as such greater mobility may paradoxically increase the risk of 
falls. In contrast, fall risks are presumably minimal for patients who are sitting on a chair all day, 
although one might argue that because of de-conditioning, particularly these patients are sus-
ceptible to fall once they do need to make a transfer or walk. Whether or not promoting physical 
activities leads to more or fewer falls really needs to be tested.
AIMS OF THIS THESIS
 Physical activity levels of patients with PD are still unclear, and so are their determinants. 
Consequently, a disease-specific intervention program considering the complexity of PD and 
their physical activity behavior is lacking. This thesis is dedicated to the relationship between 
PD and physical activity behavior, and aims to clarify some uncertainties about physical 
activity in PD.
 In Chapter 2, we examine the level of physical activity in patients with PD. Patients with PD are 
likely to become physically inactive, because of their motor, mental and emotional problems. 
However, specific studies on the actual volume of physical activity in PD are scarce, and the 
available results are conflicting. In this chapter, we quantify daily physical activities in PD pa-
tients, and analyze the associated determinants. 
 Since there is a lack of specific interventions that accommodate the complexity of PD and the 
physical activity behavior of PD patients, we developed such a PD-specific program (the ParkFit 
program). The ParkFit program is a physiotherapy intervention that aims to increase physical 
activity levels over a period of two years in sedentary patients with PD. The intervention is based 
on models of behavioral change,33 34 and contains different behavioral change techniques.35 
38 41 To evaluate its effectiveness, we designed a multicentre, randomized controlled trial com-
paring ParkFit with a matched general physiotherapy intervention.42 Primary endpoint for this 
ParkFit trial was the time spent on physical activity per week. The ParkFit program as well as the 
design of the trial are described in Chapter 3. 
 Multivariable selection methods are frequently used to determine factors associated with an 
outcome, for example in Chapter 2 when analyzing determinants of physical activity in PD. 
However, it is well known that different studies often lead to different models. By using the data 
described in Chapter 2, we show in Chapter 4 that these conflicting results are partly due to 
the fact that the final model is usually not unique.
 The ParkFit study intended to include sedentary patients, based on a physical activity screening 
questionnaire. It was uncertain whether these self-reported sedentary patients could also be 
ACHIEVING A BEHAVIORAL CHANGE; A CHALLENGE
 Despite the seemingly well-known health benefits of physical activity, almost half of the Dutch 
adults do not meet the international guidelines for healthy physical activity. Why is it so difficult 
to live an active life? Why is it easier to chose the alternative – physically inactive – option? Why 
is simply informing people about the potential health benefits of physical activity not enough 
to attain a sustained behavioral change? Everything that people can do for themselves is often 
more important than what conventional medical management can offer, but even this fact is for 
many people not enough to change their unhealthy lifestyle. Apparently, making healthy chan-
ges is easier said than done. Even when people are strongly motivated, adopting a new, healthy 
habit – and even more importantly, breaking an old one – proves very difficult. 
 Considerable research has been aimed at identifying factors and tools for clinicians that con-
tribute to a successful lifestyle change.30-32 As a first step, knowledge about the health risks and 
benefits of the specific behavior is vital: if people lack knowledge about how their habits affect 
their health, they have little reason to change these habits at all.33 Furthermore, according to 
social cognitive theories, behavior is based on two types of expectations: (1) self efficacy ex-
pectations, which are the individuals’ beliefs in their capabilities to perform a course of action 
to attain a desired outcome; and (2) outcome expectations, which are the beliefs that a certain 
consequence will be produced by personal action.33 The stronger someone believes both in his 
or her abilities and the positive outcomes of the behavior, the more likely it is that he or she will 
change the unhealthy behavior. The transtheoretical model (TTM) has been used to understand 
the stages that people progress through when they change behavior.34 The model assumes 
that individuals move through different stages: precontemplation; contemplation; preparation; 
action; and maintenance. The TTM shows that behavioral change does not occur in a linear 
manner and that it is a dynamic process.
 When trying to achieve an enduring behavioral change, both knowledge about this behavioral 
change process and specific strategies such as goal setting, problem-solving techniques and 
motivational interviewing is needed.33-35 Physical activity promoting programs including such 
elements were effective in sedentary people36 37, in patients with chronic heart failure35, and in 
patients with COPD.38
 Although an active lifestyle has extensive benefits, an increased risk for falls is a potential other 
side of the same coin. This concern is especially true for people with PD who have a much higher 
risk of falling compared to age matched controls.39 One of the most common causes of falls 
in PD appears to be freezing of gait40; other falls may result from insecure transfers or changes 
in posture, or when performing more than one activity at the same time.39 Promoting physical 
activity inevitably increases the number of daily circumstances when patients are engaged in 
16 17
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identified as being sedentary when tested objectively for daily physical activity using quantita-
tive ambulatory accelerometry. In Chapter 5, we therefore measured the daily physical activity 
levels of ParkFit patients by using an ambulatory accelerometer.
 The results of the ParkFit trial are described in Chapter 6. Primary aim of the trial is to inves-
tigate whether the ParkFit program leads to increased physical activity levels that persist for 
two years. Physical activity levels will be measured every six months using an interview-based 
7-day recall. To investigate whether increased levels of activity might be beneficial for patients, 
physical fitness and quality of life are assessed, as well as the number of falls.
 To further facilitate implementation of the ParkFit program into everyday clinical practice, we 
also evaluated the trial experience with the ParkFit program. These results are described in 
Chapter 7. 
 Finally, Chapter 8 summarizes this thesis and Chapter 9 discusses the main findings. Moreover, 
future challenges are described.
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ABSTRACT 
BACKGROUND 
 Patients with Parkinson’s disease (PD) are likely to become physically inactive, because of their 
motor, mental and emotional symptoms. However, specific studies on physical activity in PD are 
scarce, and results are conflicting. Here, we quantified daily physical activities in a large cohort 
of PD patients and another large cohort of matched controls. Moreover, we investigated the 
influence of disease-related factors on daily physical activities in PD patients. 
METHODS 
 Daily physical activity-data of PD patients (n=699) were collected in the ParkinsonNet trial, and 
of controls (n=1,959) in the Longitudinal Aging Study Amsterdam (LASA); data were determined 
using the LAPAQ, a validated physical activity questionnaire. In addition, variables that may 
affect daily physical activities in PD were recorded, including motor symptoms, depression, disa-
bility in daily life, and co-morbidity.
RESULTS 
 Patients were physically less active; a reduction of 29% compared to controls (95% CI, 10-44%). 
Multivariate regression analyses demonstrated that greater disease severity, gait impairment, and 
greater disability in daily living were associated with fewer daily physical activities in PD (R2=24%). 
CONCLUSION 
 In this large study, we show that PD patients are about one third less active compared to con-
trols. While disease severity, gait, and disability in daily living predicted part of the inactivity, 
a portion of the variance remained unexplained, suggesting that additional determinants may 
also affect daily physical activities in PD. Because physical inactivity has many adverse conse-
quences, work is needed to develop safe and enjoyable exercise programs for patients with PD.
Patients with PD are likely to decrease their 
daily physical activities, because of physi-
cal impairments, fatigue and apathy. Such 
a sedentary lifestyle is undesirable, because 
physical inactivity is a risk factor for cardio-
vascular disease, diabetes mellitus, cognitive 
impairment, osteoporosis, and depression14. 
Moreover, physical inactivity may worsen var-
ious non-motor symptoms, such as insomnia 
and constipation.
Thus far, only a few studies examined physical 
activity in PD, and the results were inconsist-
ent. Several studies found reduced levels of 
physical activity, but activity levels were not 
assessed optimally (either indirectly using 
visual analogous scales43, or using activity 
monitors mounted at the wrist, rather than the 
leg44), or studies were very small45 46. Unex-
pectedly, two studies found that patients and 
controls spent comparable amounts of time 
being active47 48. 
The determinants of physical activity in PD 
remain incompletely understood49. Generic 
factors such as age50, gender50 51, and health 
status50 are associated with the level of physi-
cal activity in healthy adults. Furthermore, 
depression is a risk factor for developing a sed-
entary lifestyle52. Such factors may also affect 
exercise behavior in patients with PD. Identify-
ing the determinants of physical activity may 
help to structure new exercise interventions. 
Here, we quantified daily physical activities in 
a large group of PD patients, and analyze the 
associated determinants, using data from the 
ParkinsonNet trial (699 patients)12 13 and the 
population-based LASA study (1,959 controls)53.
INTRODUCTION
METHODS
PARTICIPANTS
 Patients
 The ParkinsonNet trial was a cluster randomized trial involving 699 participants that evalua-
ted community-based professional networks of physiotherapists (ParkinsonNet)12 13. Eligibility 
criteria for patients were: (a) PD according to the UK PDS Brain Bank criteria2; (b) living in-
dependently in the community; (c) <80 years old; (d) able to complete the questionnaires; 
(e) MMSE>23; and (f) no severe co-morbidity interfering with daily functioning. Stage of the 
disease was scored according to the original Hoehn and Yahr (H&Y) stages54. Most patients 
(81.6%) had moderate disease severity (i.e. H&Y 2-3) (Table 2.1). Mean age was 68.6 ± 7.7 
years, 409 patients were men (58.5%), and average disease duration was 5.3 years. Full ethi-
cal approval has been granted for the study. All patients signed informed consent. In the study 
described here, we used baseline data.
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 Controls 
 Controls were derived from the Longitudinal Aging Study Amsterdam (LASA), a prospective 
study of persons aged 55 to 85 years old (1995-1996)53. This cohort forms a nationally repre-
sentative sample of the older Dutch population and thus creates a good control group. After 
exclusion of participants older than 80 years, data of 1,959 controls were available for the 
analyses. Mean age was 65.8 ± 7.0 years and 921 subjects were men (47.0%) (Table 2.1). Full 
ethical approval has been granted for the study and all respondents gave informed consent at 
the start of the study.
 Daily physical activities in patients and controls
 In both groups, daily physical activities were measured with the LASA Physical Activity 
Questionnaire (LAPAQ)55. The LAPAQ covers frequency and duration of different activities 
during the previous two weeks55 56. Activities covered in the LAPAQ include: walking outside, 
cycling, gardening, light and heavy household activities, and a maximum of two sport activities. 
To consider different levels of intensity of activities, a metabolic equivalent value (MET) was as-
signed to each activity to calculate the number of kilocalories spent per day per kilogram of body 
weight57. In addition,  types of different activities (‘inside’ and ‘outside the house’) were specifi ed. 
 The LAPAQ was initially designed as an interview-based physical activity questionnaire; in the 
LASA study, data was collected this way. A self-completed version was used in the ParkinsonNet 
trial. To reduce recall bias, the time window was limited to one week. A random sample of the 
ParkinsonNet trial population (n=76) completed the questionnaire, and was also interviewed 
similar to the controls. The subgroup was comparable to the total PD population (Table 2.1).  
DISEASE RELATED FACTORS ASSOCIATED WITH DAILY PHYSICAL ACTIVITIES IN PD
 In the ParkinsonNet trial, a wide range of variables was assessed: disease severity (H&Y stages 
and motor section of the unifi ed Parkinson’s Disease Rating Scale58), fear of falling (Falls Effi cacy 
Scale-International59), anxiety and depression (Hospital Anxiety and Depression Scale60), mo-
bility (timed up and go test61), freezing of gait (Freezing of Gait questionnaire62), walking speed 
(6-meter walk test), disability in daily life (Self-assessment Parkinson's Disease Disability Scale63), 
co-morbidity (cumulative illness rating scale64), and “faller status” (≥ 1 fall in the preceding 
year). Patient characteristics included gender, age, education level and marital status. We stu-
died the infl uence of these disease-related factors on daily physical activities. We classifi ed six 
dimensions to analyze all factors: demographics (gender, age, education level, and marital 
status); health status/disease severity (H&Y, UPDRS, CIRS, and time since diagnosis); walking 
performance/mobility (TUG, FOGQ, and walking speed); fear of falling, anxiety and depres-
sion (HADS and FES-I); disability in daily life (SPDDS); and faller status. 
Patients Controls
Total population              Random sample
N 699 76 1959
Men 409 (58.5%) 44 (57.9%) 921 (47.0%)
Age 68.6 (± 7.7) 67.6 (± 8.2) 65.8 (± 7.0)
Time since diagnosis 5.3 (± 4.7) 3.9 (± 3.7)
Education level
Low 385 (55.1%) 26 (34.2%) 1243 (63.5%)
Medium 112 (16.0%) 16 (21.1%) 367 (18.8%)
High 150 (21.5%) 25 (32.9%) 349 (17.8%)
Missing 52 (7.4%) 9 (11.8%) 0 (0.0%)
Partner
Yes 522 (74.7%) 54 (71.1%) 1451 (74.1%)
No 131 (18.6%) 13 (17.1%) 508 (25.9%)
Missing 46 (6.7%) 9 (11.8%) 0 (0.0%)
Hoehn & Yahr
1 77 (11.0%) 7 (9.2%)
2 327 (46.8%) 36 (47.4%)
3 243 (34.8%) 25 (32.9%)
4 34 (4.9%) 7 (9.2%)
Missing 18 (2.6%) 1 (1.3%)    
Data are mean (SD) or number (%).    
TABLE 2.1
CHARACTERISTICS OF THE PARTICIPANTS
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ANALYSES
 Data of daily physical activities in both groups were summarized with medians and 25th and 
75th percentiles. Since the LAPAQ scores were skewed, linear logarithmic transformation was 
applied for all subsequent analyses. Differences between patients and controls in minutes per 
day as well as in kilocalories per day were evaluated using linear regression analyses, with 
adjustment for gender, age, education level and marital status. Furthermore, linear regression 
analysis with forward variable selection was performed to study the association between the 
dimensions mentioned above and daily physical activities. First, we used a stepwise selection 
procedure to identify additional variables that contributed signifi cantly. In addition, we used a 
hierarchic approach whereby in each subsequent step of the selection procedure, an F-test was 
carried out for each dimension that was not yet in the model. First, the demographic variables 
were included in the model. The dimension with the smallest P value was then included, provided 
that it was statistically signifi cant. The selection procedure was stopped when the F-test of none of 
the remaining dimensions was signifi cant. A two-sided P value of less than 0.05 was considered 
to indicate statistical signifi cance. In general, selection procedures provide a model, but they do 
not guarantee that the model is unique. Therefore, we evaluated whether the resulted model was 
optimal and unique by calculating the explained variance (R2) for all possible alternative models.
RESULTS
DAILY PHYSICAL ACTIVITIES IN PD COMPARED TO CONTROLS
 Patients spent 111 minutes per day (interquartile range 58 – 206) on daily physical activities, 
compared to 150 minutes for controls (interquartile range 89 – 232). This amount lead to a 
29% reduction in patients versus controls (95% CI, 10 to 44%; p<0.01). Patients also spent 29% 
less kilocalories on daily physical activities (95% CI, 11 to 43%; p<0.01). After adjustment for 
age, gender, education level and marital status, the difference between patients and controls 
was 24% (95% CI, 3 to 40%; p<0.05). In contrast to the control group, the patient population 
included subjects younger than 55 years of age. Therefore, we performed an additional analysis 
excluding patients younger than 55 years old, which showed comparable results. 
 In a sub analysis, we specifi ed the nature of activities. Median time spent to ‘outdoor and sports 
activities’ did not differ between patients and controls (95% CI, 79% to 150%). However, PD pa-
tients spent signifi cantly less time to activities inside the house (62%; 95% CI, 45 to 83%; p<0.01).
 
DISEASE RELATED FACTORS ASSOCIATED WITH DAILY PHYSICAL ACTIVITIES IN PD
 Univariate relationships
 Univariate regression analyses were performed to investigate the relation between the various 
disease related factors and daily physical activities in minutes per day (Table 2.2). All disease-
related factors were signifi cantly correlated with daily physical activities, except for ‘time since 
diagnosis’. Compared to men, women with PD were 80% more active. Furthermore, time spent 
to daily physical activities decreased signifi cantly with age (-3% for each year) and with disease 
severity (-3% for each point on the UPDRS). Figure 2.1 shows that the time spent to daily phy-
sical activities decreased when disease severity increased. Additionally, patients without falls in 
the preceding year spent 32% more time to daily activities compared to fallers. Greater fear 
of falling, co-morbidity, and depression and anxiety were associated with fewer daily physical 
activities in PD.
 Multivariate relationships
 Stepwise model selection resulted in a model with four variables: gender, co morbidity, mobility, 
and disability in daily life (Table 2.2). This model explained 22% of the variance. 
 However, when we checked whether this model was unique, we found ten additional models 
FIGURE 2.1
LEVELS OF DAILY PHYSICAL ACTIVITIES PER HOEHN & YAHR STAGE (H&Y); THE ERROR BARS 
REFLECT THE 95% CONFIDENCE INTERVALS. 
*decrease is signifi cant compared to H&Y 1
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leading to 21% explained variance. In addition, the model with three variables (gender, mobi-
lity, and disability in daily life) had an explained variance of 21%. All models with fi ve or more 
variables explained at least 20% of the variance, whereas the percentage explained variance 
of the full model was 24%. We evaluated the possible collinearity in the full model. The largest 
collinearity index was 3.9 and the largest variance infl ation factor (VIF) was 2.6. Only SPDDS 
and FES-I had a VIF exceeding 2.
 Multivariate relationships: hierarchic approach
 As we could not fi nd a reasonably unique model in the multivariable approach, we used a 
hierarchic variable selection to identify dimensions which were associated with daily physical 
activities. Demographic characteristics were fi rst included in the multivariate regression model 
and explained a small portion of the variance (R2= 9%). The subsequent model selection pro-
cedure for dimensions of health resulted in a model with the dimensions walking performance/
mobility, disability in daily life, and health status/disease severity. These dimensions, in addition 
to demographics, jointly explained 24% of the variance in LAPAQ scores (Table 2.3). Adding 
more dimensions into the model did not increase the explained variance. This fi nal model was 
not unique: Table 2.3 shows that various other models yielded only slightly lower R2.
One Dimension R2 (%) Two Dimensions R2 (%) Three Dimensions R2 (%)
ADL 19 Walking, ADL 23 Severity, Walking, ADL 24
Walking 18 Severity, ADL 21 FoF & Anxiety, Walking, ADL 23
Severity 15 Severity, Walking 20 Walking, Falls, ADL 23
Falls 15 FoF & Anxiety, ADL 20 Severity, FoF & Anxiety, ADL 22
FoF & Anxiety 10 Falls, ADL 19 Severity, Falls, ADL 21
Classifi ed  dimensions: Severity = Health status/disease severity; Walking = Walking performance/Mobility; FoF & 
Anxiety = Fear of falling, anxiety and depression; ADL = Disability in daily life; Falls = Faller status.
TABLE 2.3
MODELS WITH THEIR EXPLAINED VARIANCE (R2); ALL MODELS WERE ADJUSTED FOR DEMOGRAPHIC 
CHARACTERISTICS
Covariate Univariate Regression 
(95% CI’s)
Multivariate 
Regression
Demographics
Age (years) -3 (-5, -2) *
Gender (women versus men) 80 (44, 125) * 101 (65, 141)
Education level (low, medium, high) -5 (-17, 9)
Marital status (partner versus no partner) 6 (- 20, 39)
Health status/Disease severity
H&Y Stage -34 (-43, -23) *
UPDRS III (0 – 108) -3 (-4, -2) *
CIRS (0 – 56) -28 (-38, -17) * -18 (-29, -9)
Time since diagnosis (years) -2 (-4.5, 0.3)
Walking performance/Mobility
TUG (time in seconds) -10 (-13, -8) * -7 (-10, -4)
FOGQ§ (0 – 20) -19 (-28, -10) *
Walking speed (speed in m/s) 184 (50, 389) *
Fear of Falling, Anxiety and Depression
FES-I§ (16 – 64) -65 (-74, -52) *
HADS depression (0 – 21) -7 (-9, -4) *
HADS anxiety (0 – 21) -4 (-7, -1) *
Disability in daily life
SPDDS§ (24 – 120) -82 (-87, -73) * -63 (-75, -45)
Faller status
Faller status (no versus yes) 32 (6, 65) *
H&Y Stage = Hoehn and Yahr stage; UPDRS = Unifi ed Parkinson’s Disease Rating Scale; CIRS = cumulative illness 
rating scale; TUG = timed up and go test; FOGQ = Freezing of Gait questionnaire; FES-I = Falls Effi cacy Scale-
International; HADS = Hospital Anxiety and Depression Scale; SPDDS = Self-assessment Parkinson's Disease 
Disability Scale. § = linear logarithmic transformation was applied; the coeffi cients presented here indicate the 
effect of doubling of the score: e.g. when fear of falling increased by a factor 2, daily physical activities decreased 
by 65%. * = signifi cant relationship between the independent factor and daily physical activities.
TABLE 2.2
REGRESSION COEFFICIENTS (%) AND 95% CONFIDENCE INTERVALS FOR UNIVARIATE AND 
MULTIVARIATE ANALYSES BETWEEN DAILY PHYSICAL ACTIVITIES AND THE EXPLANATORY FACTORS
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DISCUSSION
 Patients with PD are widely presumed to follow a sedentary lifestyle, due to their physical, cog-
nitive and emotional impairments. We now provide new evidence to underpin this assumption, 
based on analyses of time spent to daily physical activities in a large cohort of PD patients and 
another large cohort of controls. The loss of time spent to activities was most obvious in patients 
with greater disease severity.
 Our results showed that PD patients were 29% less active compared to controls. In a previous 
study of 24,000 subjects aged 65 years and older, similarly reduced activity levels (by about 
23%) were found for patients with a chronic disease such as musculoskeletal disorders and vas-
cular or heart diseases65. The 29% reduction observed for PD patients in the present study might 
even be greater in comparison with healthy controls since our cohort did not include severely 
affected PD patients13. Moreover, the LASA study, which we used as a control group, showed 
that about 60% of the population had a chronic disease56. Direct comparison for co morbidity 
between the two groups was not possible as the LASA study only recorded broad categories 
and did not subdivide in specific disorders. Although it would be interesting incorporating fall 
histories in the analysis, data of fall history was not available for the control group. Future studies 
are required to investigate the influence of these factors.
 It is important to consider the methods use to assess physical activity in the present and other 
studies. We used a validated interview-based physical activity questionnaire55, which is a subjec-
tive method of measuring physical activity. This might have resulted in an overestimation of the 
reported physical activities. However, this possible overestimation likely applies equally to both 
patients and controls, so it is unlikely that this influenced our results. Another possibility is that 
patients underestimated their activities due to memory problems. However, patients with severe 
cognitive impairment (MMSE <24), were excluded, so this is unlikely to explain the physical 
inactivity observed in PD patients. Other studies circumvented such problems by using objective 
measures of physical activity; these studies did not find differences between patients and con-
trols44 47 49. Although these activity monitors have been well validated and shown to be reliable 
for a range of activities, some specific activities such as gardening and cycling are difficult to 
quantify66-68. This may be one reason for the discrepancy with our results.
 We also investigated the determinants associated with daily physical activities in PD patients. 
One factor was gender. Univariate regression analysis showed that women with PD were 80% 
more active than men. This is in contrast with observations in non-PD populations50. The LAPAQ 
assessed a broad range of activities, including walking outside, cycling, gardening, light and 
heavy household activities, and a maximum of two sport activities. When we removed the 
household activities from the total activity score, men appeared to be more physically active 
than women (p<0.01). The same effect was found in the control group. This suggests that 
women spent more time to daily activities because the LAPAQ records household activities. 
Another study found comparable results for older women: two thirds of them reached recom-
mended levels of physical activity when domestic activities were included in the assessment, but 
only 21% when these domestic activities were excluded69.
 We also found several additional determinants associated with daily physical activities. 
Specifically, inactivity in PD was associated with worse walking performance, more disability in 
daily life, and greater disease severity. These factors identified in this study for PD, are compara-
ble to other studies who investigated the determinants of physical inactivity in older persons51 65 70. 
Our results concerning the determinants of daily physical activities in PD have to be interpreted 
with some caution, for several reasons. First, the final model was not unique, because various 
different combinations of determinants yielded almost the same percentage of explained vari-
ance. A model with two dimensions (i.e. walking performance and disability in daily life) was as 
good as a model with three dimensions (additionally including either disease severity, fear of 
falling, anxiety and depression, or faller status).
 Second, in all models, the unexplained variance remained large. Our final model explained 
24% of the variance. Adding more variables into the model did not increase the explained va-
riance. This suggests that additional factors are responsible for the variability in LAPAQ scores 
in PD. Because we secondary analyzed data from two previous trials, various factors were not 
investigated. One such factor is fatigue, which may be an independent contributor to physical 
inactivity in PD49. Moreover, social cognitive theories propose that behavioral factors are as-
sociated with physical activity70 71. Earlier work showed that a model which included self-efficacy 
and outcome expectations, explained 64% of the variance in exercise behavior in older adults71. 
Other studies found that (lack of) interest in physical activity, knowledge about the benefits of 
exercise, and social supports also predicted exercise behavior70-72. In the literature, many other 
possible determinants have been suggested, ranging from income and socioeconomic status up 
to seasonal effects52 73 74. Further work therefore remains necessary to identify ‘all’ determinants, 
as a basis for future therapeutic interventions. 
 Although we showed that physical inactivity was most obvious in patients with greater disease 
severity, not all PD patients with advanced disease were completely sedentary. This suggests 
that even PD patients in later stages of the disease might be stimulated to become more ac-
tive. Participating in regular physical activity would be particularly useful for PD patients, be-
cause exercise may help to prevent cardiovascular events, diabetes mellitus, and osteoporosis14. 
Moreover, in older subjects, physical activity was reported to suppress typical PD symptoms 
such as depression and cognitive decline22 75. In addition, preclinical evidence in animals with 
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experimental parkinsonism suggests that exercise may directly alter the neurodegenerative pro-
cess in PD76. A meta analysis have found exercise to be effective at improving physical functi-
oning, health-related quality of life, strength, balance and gait speed for people with PD77. It 
is therefore important for PD patients to avoid a sedentary lifestyle. Simply informing people 
about the health benefits of physical activity is likely insufficient to attain a sustained behavioral 
change. Motivational aspects are especially important because such behavioral interventions 
could target motivation to increase levels of physical activity. We are now taking this to the test 
in the ParkFit trial, a large exercise study involving 586 PD patients randomized to receive a 
behavioral change program aimed to increase daily physical activity levels. The ParkFit trial 
uses motivational strategies and personal health coaches to induce a lasting increase in exercise 
behavior for patients with PD; the first results are expected in 201242.
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METHODS      
STUDY DESIGN
 The ParkFit trial is a multicentre, randomized controlled trial comparing two arms: physiothe-
rapy with specific emphasis on promoting a physically active lifestyle (ParkFit Program); and 
matched physiotherapy with specific emphasis on safety and quality of performing daily activi-
ties (ParkSafe Program) (Figure 3.1). Trial duration is two years. Full ethical approval has been 
granted for the study (CMO Regio Arnhem-Nijmegen). The study is registered at clinicaltrials.gov 
(nr NCT00748488).
Parkinson’s disease is a progressive neuro-
logical disorder characterized by both motor 
symptoms (such as bradykinesia and postural 
instability) and non-motor symptoms (such as 
depression and cognitive impairment).5 Both 
motor and non-motor symptoms can result in 
reduced physical activity.43 78
Observations in non-parkinsonian popula-
tions suggest that participating in regular 
physical activity has preventive effects (e.g. 
cardiovascular events, diabetes mellitus, de-
mentia)14 23 79 and positive symptomatic ef-
fects (on depression75, sleep disturbances80, 
health-related quality of life).81 Studies in PD 
patients concluded that brief physiotherapy 
interventions can improve flexibility, balance 
and muscle strength.82 83 In addition, preclini-
cal evidence in animals with experimental par-
kinsonism raised the possibility that physical 
activity may directly alter the neurodegenera-
tive process.76 84 
A critical question remains how PD patients 
can be stimulated best to achieve an enduring 
increase in their physical activities in daily life, 
in order to prevent co-morbid complications 
and to improve symptoms. Simply informing 
subjects about the health benefits of physical 
activity is not enough to attain a sustained be-
havioral change. The challenges to induce a 
lasting change in exercise behavior are par-
ticularly great for neurological patients. To 
change lifestyle, behavioral programs should 
focus on appropriate supervision, social sup-
port from spouses and caregivers, and the 
individual’s preferences and needs.33 35 36 
Achieving an enduring behavioral change 
also calls for specific strategies such as goal 
setting, problem-solving techniques and 
motivational interviewing.33-35 Physical activ-
ity promoting programs including such ele-
ments were effective in sedentary people36, 
patients with chronic heart failure35, and 
patients with COPD.38 
Stimulated by these observations, we devel-
oped the ParkFit program: a multifaceted 
intervention to promote physical activity in 
sedentary patients with PD. In addition, we 
developed the ParkFit trial to investigate 
whether this program affords increased physi-
cal activity levels that persist for two years. 
The trial will also search for possible health 
benefits and risks of increased physical activ-
ity. Here, we describe the study design and 
baseline characteristics of this ParkFit trial.
INTRODUCTIONABSTRACT 
BACKGROUND 
Many patients with Parkinson’s disease lead a sedentary lifestyle. Promotion of physical activities 
may beneficially affect the clinical presentation of PD, and perhaps even modify the course of 
PD. However, because of physical and cognitive impairments, patients with PD require specific 
support to increase their level of physical activity.
METHODS
 We developed the ParkFit Program: a PD-specific and multifaceted behavioral program to pro-
mote physical activity. The emphasis is on creating a behavioral change, using a combination of 
accepted behavioral motivation techniques. In addition, we designed a multicentre randomized 
clinical trial to investigate whether this ParkFit Program increases physical activity levels over two 
years in sedentary PD patients. We intended to include 700 sedentary patients. Primary end-
point is the time spent on physical activities per week, which will be measured every six months 
using an interview-based 7-day recall.
RESULTS
 In total 3453 PD patients were invited to participate. Ultimately, 586 patients – with a mean 
(SD) age of 64.1 (7.6) years and disease duration of 5.3 (4.5) years – entered the study. Study 
participants were younger, had a shorter disease duration and were less sedentary compared 
with eligible PD patients not willing to participate.
CONCLUSION
 The ParkFit trial is expected to yield important new evidence about behavioral interventions to pro-
mote physical activity in sedentary patients with PD. The results of the trial are expected in 2012.
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PATIENTS
 We started with all patients who visited their neurologist in 2007, 2008 or 2009 in 32 parti-
cipating community hospitals. Eligibility criteria were: (a) PD, according to the UK Brain Bank 
Criteria2;  (b) age between 40 and 75 years; (c) sedentary lifestyle defi ned as: <3 times a week 
vigorous-intensity physical activity for <60 minutes; or <3 times a week moderate-intensity 
physical activity for <150 minutes);15 (d) Hoehn and Yahr ≤3. Exclusion criteria were: (a) unclear 
diagnosis (no gratifying and sustained response to dopaminergic therapy); (b) MMSE <24); (c) 
unable to complete Dutch questionnaires; (d) severe co-morbidity interfering with daily functio-
ning; (e) daily institutionalized care; and (f) deep brain surgery. Informed consent was obtained 
before the fi rst assessment. 
THE INTERVENTION  
 After baseline assessment, patients were randomly assigned to the ParkFit or ParkSafe 
Program. In both groups, patients receive high quality physiotherapy: both interventions are 
delivered exclusively by experienced therapists who participate in the Dutch ParkinsonNet.12 13 
Patients in both treatment arms are offered an equal maximum number of treatment sessions 
(i.e. 35 sessions of 30 minutes a year; Table 3.1). Therapists contact patients at least every six 
months to investigate if there are new aims.
FIGURE 3.1
DESIGN OF THE PARKFIT STUDY
ParkFit ParkSafe
Intensity Maximum of 19 physical therapy sessions Maximum of 35 physical therapy sessions
Year 1 based on problems and disabilities as perceived by 
each individual patient
based on problems and disabilities as perceived by 
each individual patient
16 coaching sessions
to identify and focus on individual beliefs and aims to 
promote a physically active lifestyle
Intensity Maximum of 23 physical therapy sessions Maximum of 35 physical therapy sessions
Year 2 based on problems and disabilities as perceived by 
each individual patient
based on problems and disabilities as perceived by 
each individual patient
12 coaching sessions
to identify and focus on individual beliefs and aims to 
promote a physically active lifestyle
Speciﬁ c ParkFit Brochure ParkSafe Brochure
Elements •  Education about beneﬁ ts of physical therapy • Education about beneﬁ ts of physical therapy 
•  Identifying aims of physical therapy • Identifying aims of physical therapy
•  Education about the beneﬁ ts of physical activity • Education about the importance of safety when 
    performing daily activities
•  Identifying barriers to engage physical activity
•  Setting goals
•  Recruiting social support
• Sign a health contract to support patients in 
    initiating and maintaining physical activities
•  A logbook to describe and monitor the speciﬁ c goals
Physical therapist Physical therapist 
who treat the patient in order to obtain the aims of the indi-
vidual projected treatment plan
who treat the patient in order to obtain the aims of the 
individual projected treatment plan
Personal Activity Coach 
who guide patients towards a more active lifestyle
Goal setting: 
creating goals to increase the level of physical activity 
in order to obtain the half-year-goals as formulated in 
the health contract
Ambulatory Activity Monitor
gives visual feedback about the level of physical activity 
during the day
Bi-annual newsletter Bi-annual newsletter
specifi c information about physical activity, general 
information about Parkinson’s disease, and general 
entertainment in order to facilitate compliance
specifi c information about physical activity, general 
information about Parkinson’s disease, and gener-
al entertainment in order to facilitate compliance
TABLE 3.1
THE PARKFIT AND THE PARKSAFE PROGRAM
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 ParkFit Program
 Widely used behavioral change techniques, with demonstrated effectiveness35 38 and based on 
models of behavioral change33 34, are combined in the ParkFit Program to stimulate patients to 
increase their physical activity levels. 
 1) Brochure ParkFit
 Patients receive a brochure covering specific strategies to promote a behavioral change. These 
strategies include: education about the benefits of physical activity, advice about suitable acti-
vities, identifying and overcoming any perceived barriers to engage in physical activity, setting 
goals, and recruiting social support.33 85 86 Part of the educational workbook is a health contract: 
a written agreement signed by the patient and physiotherapist to support them in initiating and 
maintaining physical activities.41 A logbook monitors the specific goals. 
 2) Personal Activity Coach 
 Physiotherapists serve as personal activity coaches who guide patients towards a more active 
lifestyle, during specific coaching sessions. Their task is to educate patients about the beneficial 
effects of physical activity. Patients are additionally stimulated to participate in group exercise 
to experience the beneficial effects of physical activity and to receive social support from fel-
low patients.71 For safety reasons, all patients are encouraged to receive a preventive sports 
medical screening.
 3) Goal setting
 Patient and coach create activity goals in order to obtain the 6-month-goals (as formulated 
in the health contract). Goals have to be realistic, concrete and individualized and have to be 
formulated in a systematic way, based on behavioral change theories.41
 4) Ambulatory Activity Monitor with visual feedback
 Patients receive a personal ambulatory monitor with automated visual feedback showing the 
amount of actually delivered daily physical activity, recorded by a triaxial accelerometer.87 88 
Additionally, a personalized website shows the activity history.87 Previous work showed that feed-
back from pedometers increases physical activity levels in COPD patients89, sedentary workers90 
and patients with diabetes mellitus.91 
 5) Physiotherapy
 The ParkFit Program also includes a maximum of 19 physiotherapy sessions in year 1 and 23 
in year 2. Based on individual disabilities, therapist and patient jointly formulate treatment aims 
based on the evidence-based guideline of physiotherapy for PD.11
 ParkSafe Program
 The ParkSafe Program includes physiotherapy interventions from the physiotherapy guideline for 
PD11 to stimulate patients to move more safely,  e.g. by improving the quality of transfers, but 
without explicit emphasis on reaching a physically active lifestyle. 
 1) Brochure ParkSafe
 Patients receive a brochure with information about the benefits of physiotherapy.11 Specific emp-
hasis is given to the importance of safety when performing daily activities. 
 2) Physiotherapy
 Patients receive an individualized physiotherapy program. We maximized the total number of 
sessions at 35/year, to avoid large differences in number of treatment  sessions between the 
two arms (patients in the ParkFit arm also receive 35 annual sessions: 19 physiotherapy plus 16 
coach sessions). 35 sessions is considered sufficient for patients in Hoehn and Yahr stage ≤3. 
Physiotherapist and patient jointly formulate the aims of the projected treatment plan, based on 
individual problems and disabilities. The aims of the physiotherapy sessions in both treatment 
arms are derived from the guideline for physiotherapy in PD.
IMPLEMENTATION
 Training for physiotherapists
 All participating physiotherapists were specifically trained to treat patients in both treatment 
arms and informed about the aim of the study. Special attention was given to models of behavi-
oral change,33 34 to specific strategies of coaching sedentary patients,36 92 and to the technique 
of setting realistic, concrete and individualized goals.41 Throughout the trial, therapists conti-
nuously register the individual treatment sessions.
OUTCOME MEASURES
 Baseline characteristics
 Blood pressure, height, body weight, education and employment are assessed at baseline as well as 
alcohol use, smoking history and lifetime physical activity.93 Participants in the ParkFit Program also 
completed a questionnaire about attitude, social support and self-efficacy towards physical activity. 
 Primary endpoint: level of physical activity 
 Primary endpoint is the level of physical activity, as measured with a 7-day recall, based on an 
interview-based physical activity questionnaire, the LAPAQ.55 Patients are asked to list their daily 
amount of activity (frequency and duration), so total time spent on physical activity (in hours per 
day) will be calculated. A MET-value will be used to calculate the number of kilocalories spent 
per day per kilogram of body weight.94 The LAPAQ is completed during a face-to-face interview 
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(at baseline, 12 and 24 months) and at additional time points by telephone (6 and 18 months). 
We assume that patients will increase their level of physical activity during the fi rst months of 
intervention and then maintain this level. Therefore, main endpoint is the level of physical activity 
during the entire follow-up period (i.e. the mean of 6, 12, 18 and 24 months).
 Secondary endpoints (Table 3.2)
 Secondary measures include: (a) physical fi tness, measured with the six minute walk test (6MWT)95; 
(b) quality of life, measured with the PDQ-3996; and (c) level of physical activity in time and kiloca-
lories per week, measured with the same tri-axial accelerometer that is used as feedback-tool in the 
ParkFit Program.88 The level of physical activity is additionally measured with a physical activity diary. 
 Additional measures
 Patients who increased their amount of physical activity will be compared with patients unable 
to achieve this, to assess specifi c health consequences. Disease progression (UPDRS motor 
section58; 9-hole peg board test97), mobility (Timed Up and Go test61), quality of sleep (SCOPA-
sleep98), anxiety and depression (HADS60), fatigue (Fatigue Severity Scale99), and cognitive func-
tioning (Table 2 for test battery) are assessed. Additionally, physical fi tness is measured with 
the Åstrand-Ryhming test.100 Bone mineral density (dual energy X-ray absorptiometry, DXA) is 
determined in a subgroup of 300 patients. PD medication and medical costs (combined with the 
EQ-5D101) are assessed, as well as the number of falls (as an index of safety). Patients are asked 
whether their falls occurred during exercise and about the consequences of falls (e.g. injuries). 
Information about other adverse events is collected systematically at each physical assessment.
 Blinding 
 To avoid bias due to more positive expectations of patients towards the outcomes of the ParkFit 
Program, patients were initially informed about the fact that there are two intervention groups, 
each with a benefi cial intervention. To ensure blinding during assessments, patients are as-
sessed by trained assessors who are unaware of group allocation. Patients are explicitly asked 
to not share their experiences with the program during the assessments. 
 Sample size calculation 
 Based on the following power considerations, we aimed to include a total of 700 patients. In 
a small observational study on physical activity in PD, patients scored 45% less on the LAPAQ 
compared to controls (unpublished data). The coeffi cient of variation was 110%. Based on a 
difference of 15% (with coeffi cient of variation of 110%) between both treatment arms, the study 
will have at least 80% power (when the correlation between baseline and follow-up measure-
ments is at least 0.50 and when the correlation between the various follow-up measurements 
is at most 0.85). This is also the power when the correlations are at least 0.60 and at most 
Baseline
Visit &
Questionnaires
6 months
Questionnaires
12 months
Visit &
Questionnaires
18 months
  
Questionnaires
24 months
Visit &
Questionnaires
Physical Activity
LAPAQ x x x x x
Activity Monitor x x x x x
Activity Diary x x x x x
Physical Fitness
6 MWT x x x
Åstrand-Ryhming test x x x
Quality of Life
PDQ-39 x x x x x
Health Effects
UPDRS III, motor function x x x
Nine hole peg board test x x x
Timed up and go test x x x
DXA x
SCOPA-sleep x x x x x
HADS x x x x x
FSS x x x x x
Cognitive testing battery* x x x
PD medication x x x x x
Medical costs & EQ-5D x x x x x
Number of falls (monthly) x x x x x
Determinants
Blood pressure x x x
Height x x x
Body weight x x x
Education x
Employment x
Alcohol use x x x
Smoking x x x
Lifetime physical activity x
Attitude, SS & SE** x
* Including tests for spatial working memory, intra- and extra-dimensional shift performance, paired associate learning 
performance, phonemic and semantic word fl uency, and complex fi gure drawing
 ** Only patients in the ParkFit Program 
TABLE 3.2
AN OVERVIEW OF PATIENT ASSESSMENTS
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0.95, respectively. The power is based on two-sided 95% confi dence intervals. We assumed 
that patients would take part in exercise groups with on average eight participants and that the 
corresponding ICC would be 0.1. Based on a previous trial of physiotherapy for PD involving the 
national ParkinsonNet networks13, we expect a drop-out rate of 10%. 
 Randomization 
 A minimization algorithm is used to randomize patients, with the factors region, Hoehn & Yahr 
stage, age, gender and current level of physical activity.
 Statistical analyses
 All participants who really started with their program, will be included in the primary analysis. 
The results after 6, 12, 18 and 24 months will be evaluated using a linear mixed model with ran-
dom nested factors ‘patient’ and ‘exercise group’. Fixed factors will be treatment arm, LAPAQ 
score at baseline, month, month*treatment (interaction), and the factors region, H&Y stage, age, 
gender and bone density assessment. In an additional analysis, the infl uence of H&Y stage, age, 
gender and level of previous sports activities on the success of the treatment will be evaluated 
by including the interaction terms between treatment and each of these variables in the model. 
Multiple imputation analyses will be used to evaluate the impact of missing values on the out-
come. Throughout, 95% confi dence intervals will be calculated.
RESULTS 
INCLUSION PROCEDURE
 Selection of patients ran from September 2008 to January 2010. A total number of 4479 pa-
tients received a screening questionnaire; 587 (13.1%) did not respond, 439 (9.8%) were exclu-
ded because there was doubt about the diagnosis (Figure 3.2). After invitation for participation, 
1766 patients were excluded based on our exclusion criteria, and 1101 eligible patients were 
excluded because they were not willing to participate. Finally, 586 patients signed informed 
consent. The number of enrolled patients is less than the power calculation required. However, 
the power remains over 80% because only 60% of patients participates in exercise groups with 
an average group size of only three, whereas our power calculation assumed that all patients 
would participate in exercise in groups of eight patients.
BASELINE CHARACTERISTICS
 The most relevant baseline characteristics of included patients are presented in Table 3.3 and 
compared with the characteristics of the complete cohort of PD patients and the cohort of patients 
who were eligible but not willing to participate. Study participants were younger, had a shorter 
disease duration and were less sedentary compared with eligible patients not willing to participate.
FIGURE 3.2
FLOW CHART OF THE INCLUSION PROCEDURE
 Legend: * No Parkinson’s disease = patient is diagnosed with parkinsonism or patient declared to have no grati-
fying and sustained response to dopaminergic therapy;  ** No sedentary lifestyle = > 3 times a week vigorous-
intensity physical activity > 60 minutes; or > 3 times a week moderate-intensity physical activity > 150 minutes; 
*** Severe disease = H&Y > III; MMSE <24; severe co-morbidity interfering with daily functioning; use of daily care 
in an institution; or deep brain stimulation.
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Variable Complete cohort 
of PD patients
Eligible patients
Not willing to participate  Willing to participate
N 3453 1101 586
Gender (% male) 59.0 53.4 65.4
Age (years) 66.1 (7.2) 67.2 (7.1) 64.1 (7.6)
Disease duration (years) 6.2 (5.7) 6.0 (5.6) 5.3 (4.6)
Ability to walk (%)
Normal 814 (23.7) 232 (21.3) 157 (26.8)
Slow but independently 1747 (50.8) 556 (51.0) 348 (59.4)
Independently with walking aid 605 (17.6) 302 (27.7) 81 (13.8)
With help of someone 112 (3.3) -3.7 to 0.7
Wheelchair bounded 158 (4.6) 0.2 to 0.9
Level of physical activity (min/week) 144.8 (196.7) 40.1 (61.1) 59.2 (71.9)
TABLE 3.3
CHARACTERISTICS OF THE INVITED AND INCLUDED PATIENTS 
DISCUSSION
 Several lines of evidence suggest that regular participation in physical activity could be important for 
patients with PD.77 The ParkFit trial was designed to evaluate a multifaceted program to achieve an 
enduring increase in physical activity in PD patients. The intervention is based on accepted motivati-
onal and behavioral change models33-35, which will now be employed for the fi rst time in PD.
 We carefully monitored the characteristics of all invited patients as well as eligible patients who 
were not willing to participate. The results demonstrate that among all PD patients who were 
invited, 64% indeed had a sedentary lifestyle. The results further demonstrate that eligible PD 
patients not willing to participate were on average somewhat more sedentary in comparison with 
the participants of the study. Should our study shows a benefi cial effect of the ParkFit behavioral 
change program, efforts must be made to also reach out to this subgroup of sedentary patients.
 A critical issue in rehabilitation studies is the choice for an appropriate control conditi-
on, and we have selected a program that emphasized safety of movement (according to 
evidence-based guidelines11), rather than the quantity of movements. Both intervention pro-
grams are matched for intensity, and are delivered by the same therapists. We have taken 
several measures to avoid bias between both treatment arms, rendering both groups com-
parable except for the focus on physical activities. Because the same therapists participate in 
both programs, differences in their personalities should not differ between the two treatment 
arms. A possible drawback is contamination. Furthermore, personal preference for a specifi c 
program can possibly introduce variation between therapists. We strive to avoid this by: (1) 
specifi c training, informing all therapists about the aim of the study and the do’s and don’ts 
in both treatment arms. They have signed a contract and agreed to keep both programs se-
parate. (2) The tools used in ParkFit are not freely available. Since all patients receive  their 
own Activity Monitor and brochure, therapists cannot give these tools to patients allocated to 
ParkSafe. (3) During the trial, therapists are being visited and observed during one or more 
sessions. A standardized checklist of prescribed interventions will be completed to investigate 
if contamination is at play. (4) Each therapist will be interviewed, between 3 to 6 months after 
start of the program. The aim is to investigate how therapists put the program into practice, 
and to re-emphasize the do’s and don’ts of both programs. (5) About every two months, the 
research team contacts each therapist to ask them about their individual aims in both treat-
ment arms. Again, it is emphasized that coaching towards a more physically active lifestyle 
is not allowed in ParkSafe. (6) Yearly, a ‘booster’ session is planned for therapists to discuss 
possible problems and to re-emphasize the do’s and don’ts. 
 A strong element of the ParkFit trial is the availability of our national ParkinsonNet networks13, 
which allows us to administer the interventions in both treatment arms by therapists with docu-
mented experience in treating PD patients. The ParkFit trial is one of the largest and longest 
lifestyle intervention trials in PD, and is the fi rst one to focus on behavioral change as an 
intermediate to achieve a sustained increase in physical activity levels.
 The endpoints of this trial cover several complementary domains. A prerequisite is that pa-
tients will actually increase their physical activity levels. To document this, we have selected 
the time spent on physical activities per week as primary endpoint. We choose the LAPAQ as 
primary outcome measure instead of the Activity Monitor because a questionnaire covers a 
wider range of activities.68 
 We also want to see whether physical activity affords any symptomatic relief of PD. To this 
end we have included a battery of additional endpoints (including quality of life) that measure 
possible health benefi ts for patients. Safety is also an issue, because physical activity may 
theoretically predispose patients to falls. Therefore, this will also be documented in this study. 
Furthermore, costs will be recorded, although we have no specifi c a priori reason to expect 
drastic increases or reductions in costs associated with the interventions of this trial.
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Netherlands), W. Oerlemans (HAN University of Applied Sciences), C.J.M. van Santen (Society 
of Exercise Therapists Cesar and Mensendieck), N.H.M.J. van Velthoven (Netherlands Olympic 
Committee * Netherlands Sports Federation), A.M.J. van de Wert (Netherlands Institute for 
Sport en Physical Activity), and T. Wolff (Parkinson Vereniging) for their participation in the 
ParkFit advisory board.
 In conclusion, the ParkFit trial is expected to yield important new knowledge about behavioral 
interventions for patients with PD to change their sedentary lifestyle. If the ParkFit Program shows 
good treatment compliance and beneficial symptomatic effects, future trials could identify which 
components of our multifaceted approach are most effective. In addition, positive results may 
have implications for different neurological disorders where beneficial effects of physical activity 
may be expected. The results of the ParkFit trial are scheduled for 2012. 
ACKNOWLEDGEMENTS
 This research is supported by grants from ZonMw, The Netherlands Organization for Health 
Research and Development (75020012), and the Michael J Fox Foundation for Parkinson’s 
research. Furthermore, health insurer VGZ financially supported the ParkFit study. Professor 
Bastiaan R. Bloem was supported by a NWO VIDI grant (016.076.352).
 We would like to thank the local coordinators of the participating general hospitals:
 A. Winogrodzka (Academisch Ziekenhuis Maastricht); J.C.M. Zijlmans (Amphia Ziekenhuis); 
G.J. Tissingh (Atrium Medisch Centrum); K. Keizer (Catharina-ziekenhuis);  H.J.M.M. Lohmann 
(Deventer Ziekenhuis); R. van Koningsveld (Elkerliek Ziekenhuis); A.J.W. Boon (Erasmus Medisch 
Centrum); E. van Wensen and F.E. Strijks (Gelre Ziekenhuizen); G.A. van Meer (Groene Hart 
Ziekenhuis); A. Mosch (HagaZiekenhuis); J.P. ter Bruggen (Jeroen Bosch Ziekenhuis); M.F. 
Roesdi (Kennemer Gasthuis); E. Berger (‘t Lange Land Ziekenhuis and Medisch Centrum 
Haaglanden); A.G.G.C. Korten (Laurentius Ziekenhuis); M. Westerink (Maasstad Ziekenhuis); 
M. Aramideh (Medisch Centrum Alkmaar); R. Rundervoort (Medisch Centrum Haaglanden); F.A. 
Rooyer (Orbis Medisch Centrum); D.J. Kamphuis (Reinier de Graaf Groep); G.J. de Jong (Sint 
Franciscus Gasthuis); L. van Hooff (Franciscus Ziekenhuis); K. Lemmen (Slingeland Ziekenhuis); 
Th.J.M. Breuer (St. Anna Ziekenhuis); J.M.J. Krul and P.M. Laboyrie (Tergooiziekenhuizen); 
F.J.W. Opstelten (VieCuri Medisch Centrum); A.M.G. Sas (Vlietland Ziekenhuis); P.J. Nederveen 
(Westfriesgasthuis), J. Lion (Ziekenhuis Bernhoven); and C. Jansen (Ziekenhuis Gelderse Vallei) 
for their participation in the ParkFit study group.
 Furthermore, we would like to thank J.W. Custers and P.J. van der Wees (Royal Dutch Society for 
Physiotherapy), S.I. Detaille and V. Peters (Seneca, Expertise Centre for Sport, Work and Health, 
HAN University of Applied Sciences), M.T. Hopman (Department of Physiology, Radboud 
University Nijmegen Medical Centre), M.W.A. Jongert (TNO Netherlands Organization for 
Applied Scientific Research), Y.P.T. Kamsma (University Medical Center Groningen), S.H.J. Keus 
(Departments of Physiotherapy and Neurology, Leiden University Medical Centre; Department of 
Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Nijmegen 
Medical Centre), G. Kwakkel (VU University Medical Center), H. Leutscher (Disability Sports 
04CHAPTERMULTIVARIABLE ANALYSES OFTEN 
HAVE MULTIPLE 
SOLUTIONS, ALL 
OF WHICH SHOULD 
BE REPORTED
SUBMITTED
Marlies van Nimwegen, Arlène D Speelman, and George F Borm
promotion of physical activity in parkinson's disease • the challenge to change behavior
50 51
multivariable analyses often have multiple solutions, all of which should be reported 0404
ABSTRACT
BACKGROUND
 When variable selection methods are used to determine the factors that are associated with an 
outcome, the selected model may not be unique. In general, as the number of factors increases, 
the number of models that fit the data also increases. To illustrate this, we describe a study that 
seeks to identify factors associated with the level of physical activity in patients with Parkinson’s 
disease (PD).
METHODS
 This example was based on a fairly large data set of 699 patients. Multivariable linear regres-
sion was used to evaluate the relationship between patients’ physical activity level and a number 
of individual and disease-related factors. To evaluate to what extent the model was unique, we 
calculated the percentage explained variance (R2) of all possible models.
RESULTS
 The forward selection method resulted in a model with four variables (R2=22%); the model with 
all fourteen variables explained 24% of the variance. We identified ten models, each with four va-
riables, that each explained 21% of the variance; numerous other models had only a slightly lower 
R2. In addition, the best-fitting model with three variables also had an explained variance of 21%.
 
CONCLUSION
 Several models seem appropriate to describe the relationship between the independent factors 
and the physical activity level in PD. We propose that all models with approximately the same fit 
should be reported in addition to the final model that results from the variable selection proce-
dure. Such an approach would show the uncertainty of the results of the model selection in the 
same way that confidence intervals present the uncertainty of a quantitative outcome. Presenting 
all models makes it possible to evaluate the extent to which the best-fitting models overlap and 
aids in comparing and pooling the results of different studies. This approach depicts the uncer-
tainty of the results and avoids unnecessary discussions when investigators find other models.
Variable selection methods are frequently 
used to generate a multivariable model to de-
termine which factors may predict or influence 
a certain disease or a specific outcome. How-
ever, the final model may include variables 
that should not have been selected, whereas 
other important variables may have been in-
appropriately excluded.102-114 Moreover, sev-
eral additional models may fit the data almost 
as well as the selected model, suggesting that 
the selected model is not unique. Several rea-
sons may explain this uncertainty. 
First, the final selected model depends on the 
statistical variable selection procedure. For 
example, a model obtained through forward 
selection may differ from a model obtained 
through backward selection or stepwise selec-
tion; additional selection methods may lead to 
other models. Additionally, the final selected 
model depends on inclusion or exclusion cri-
teria. Therefore, even when the same selec-
tion method is used, the final selection models 
may vary. For example, using forward selec-
tion, a model generated using an inclusion 
criterion of p<0.05 will be different from a 
model generated using an inclusion criterion 
of p<0.01. Moreover, as larger data sets tend 
to lead to models with more variables, the size 
of the data set also influences the final model.
Even when exactly the same methods and cri-
teria are used, the reproducibility of the results 
may still be of concern.102-114 This possibility 
may be in part due to differences between 
data sets, but also to the nature of multivari-
able data. When the independent variables 
are either strongly associated with the out-
come or are not associated with the outcome, 
selecting a model may be straightforward. 
However, there may also be variables that are 
weakly associated with the outcome of inter-
est. Therefore, it may be impossible to make 
an unambiguous distinction between vari-
ables with a true or spurious association with 
the outcome. In addition, because several 
variables may measure the same or overlap-
ping constructs, it may be difficult to make a 
selection. Consequently, a unique model may 
be practically impossible to identify. 
Good statistical practice requires a measure 
of the precision or reliability of the statistical 
analysis to be reported. For that purpose, p-
values and confidence intervals are reported, 
showing a range of results that are compat-
ible with the data. In this study, we suggest a 
similar approach for the selection of multivar-
iable models. We propose that reports should 
investigate whether the result of the selection 
procedure is unique, or if other models lead 
to approximately the same fit. In the latter 
case, the additional models should also be 
presented. This approach demonstrates the 
reliability of the model selection procedure. 
To illustrate this approach, we describe a 
study that seeks to identify factors associated 
with the level of physical activity in patients 
with Parkinson’s disease (PD).
INTRODUCTION  
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METHODS
 PD is a progressive neurological disease.5 Although medical treatment substantially improves 
patients’ quality of life and functional capacity, PD remains an incurable disease. Recent studies 
using rodent models have shown that exercise may have a beneficial effect in the manage-
ment of PD. 76 However, patients with PD are heavily inclined toward a sedentary lifestyle. 
Consequently, it is a challenge to encourage patients to become more active. Information per-
taining to the patients’ physical activity level is needed to develop appropriate ‘exercise advice’. 
Data were derived from the ParkinsonNet trial, a randomized trial evaluating the impact of 
community-based networks of professional physiotherapists (ParkinsonNet) on healthcare costs 
and health outcomes.13 The trial has been approved by the appropriate ethics committee and 
all persons gave their informed consent prior to inclusion in the study. 
 Multivariable linear regression was used to evaluate the relationship between patients’ phy-
sical activity level and a number of individual and disease-related factors.115 Physical activity 
was measured using an interview-based questionnaire, specifically, the LASA Physical Activity 
Questionnaire (LAPAQ).55 The independent variables included gender, age, education level, 
marital status, disease severity (Hoehn and Yahr [H&Y], and the motor section of the Unified 
Parkinson’s Disease Rating Scale [UPDRS]), cognitive function (mini mental state examinati-
on [MMSE]), fear of falling (Falls Efficacy Scale-International [FES]), anxiety and depression 
(Hospital Anxiety and Depression Scale [HADS]), mobility (Timed Up and Go Test [TUG]), free-
zing of gait (Freezing of Gait Questionnaire [FOGQ]), disability in daily life (Self-Assessment 
Parkinson’s Disease Disability Scale [SPDDS]), co-morbidity (Cumulative Illness Rating Scale 
[CIRS]), and ‘faller status’ (≥ 1 fall in the preceding year versus no fall). 
 A two-sided p-value <0.01 was used as a threshold for inclusion in the model. We choose 
p<0.01 because the data set was rather large (699 patients). Therefore, even an irrelevant 
variable could result in statistical significance. For example, in univariate analyses, variables 
reaching significance at p<0.05 were found, even when the percentage of explained variance 
(R2) was only 1%. In addition, many variables were statistically tested for inclusion in the model; 
therefore, an adjustment of the significance level, for example a Bonferoni correction, could 
be appropriate. To the best of our knowledge, no guidelines exist describing how or whether 
to carry out such an adjustment. A small p-value may be appropriate when one is interested in 
excluding irrelevant variables at the cost of missing some variables that are only weakly associa-
ted with the outcome. When one wants to capture all potential variables at the cost of capturing 
spurious associations, a larger p-value may be appropriate.
 To evaluate to what extent the model was unique, we carried out the all subset selection method, 
i.e. we calculated the percentage explained variance (R2) of all possible models.116 In this way, 
we identified all models with an R2 similar to the R2 of the model obtained from the forward 
selection procedure.
RESULTS
 The forward selection method resulted in a model with four variables: gender, co morbidity, 
mobility, and disability in daily life. This model explained 22% of the variance. Although this R2 
value indicated a poor fit, additional variables were unlikely to contribute to a better fit because 
the model with all fourteen variables explained only 24% of the variance.
 To identify models with a comparable fit, we calculated the percentage explained variance (R2) 
of all other possible models. Table 4.1 shows a selection of these results. The second column 
in the table lists the variables in the models. The third column shows the accompanying R2. We 
identified ten models, each with four variables, that each explained 21% of the variance; nu-
merous other models had only a slightly lower R2. In addition, the best-fitting model with three 
variables (gender, mobility, and disability in daily life) also had an explained variance of 21%. 
Because a difference of 1% is well within the error margin of the R2 (the standard error of R2 is 
approximately 2.5%), there is no evidence that the models with 22% explained variance are bet-
ter compared to the models with an R2 of 21%. As a result, several models seem appropriate to 
describe the relationship between the independent factors and the physical activity level.
 Table 4.2 shows the details of the best fitting models. The coefficients of the variables are quite 
similar across models, suggesting that the results are stable and robust. Regression models 
become particularly unstable when the number of variables in the model is high (‘overfitting’), 
or when multicollinearity is present 116. Because the number of variables included in the analysis 
was limited compared to the number of observations, overfitting may not be an issue. In ad-
dition, the variance inflation factors were all less than 2.6, meaning that there was no indication 
of multicollinearity.
 As some of the independent variables had a correlation of greater than 0.5 and may measure 
overlapping constructs, we repeated the analysis with only seven variables: gender, age, educati-
onal level, marital status, UPDRS, MMSE and CIRS. These variables measure different constructs 
and all have correlations of less than 0.25. The full model with these seven variables had an R2 
of 15%. Forward selection led to a model with four variables, including gender, age, UPDRS and 
CIRS, and had an R2 of 13%. In addition, several models had an R2 greater than 12%, including 
one model with three variables and four models with four variables (results not shown). 
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Nr of variables Variables in the model R2
1 SPDDS 0.12
2 Gender, SPDDS 0.17
3 Gender, TUG, SPDDS 0.21
Gender, CIRS, SPDDS  0.19
Gender, Age, SPDDS 0.19
Gender, CIRS, TUG 0.18
Gender, TUG, FES 0.18
Gender, H&Y, SPDDS 0.18
Gender, Marital Status, SPDDS 0.18
Gender, FES, SPDDS 0.18
Gender, UPDRS, SPDDS 0.18
Gender, FOGQ, SPDDS 0.18
Gender, MMSE, SPDDS 0.18
Gender, Age, TUG 0.17
Gender, Faller, SPDDS 0.17
Gender, Education, SPDDS 0.17
4 Gender, CIRS, TUG, SPDDS 0.22
Gender, TUG, FOGQ, SPDDS 0.21
Gender, Age, TUG, SPDDS 0.21
Gender, Education, TUG, SPDDS 0.21
Gender, Marital Status, TUG, SPDDS 0.21
Gender, HADS, TUG, SPDDS 0.21
Gender, H&Y, TUG, SPDDS 0.21
Gender, TUG, Faller, SPDDS 0.21
Gender, MMSE, TUG, SPDDS 0.21
Gender, UPDRS, TUG, SPDDS 0.21
Gender, TUG, FES, SPDDS 0.21
Gender, Age, CIRS, SPDDS 0.20
Gender, CIRS, TUG, FES 0.20
Gender, H&Y, CIRS, SPDDS 0.20
5 Gender, CIRS, TUG, FOGQ, SPDDS 0.22
6 Gender, Age, CIRS, TUG, FOGQ, SPDDS 0.23
14 Gender, Age, Marital Status, Education, H&Y, UPDRS, CIRS, MMSE, 
HADS, TUG, FOGQ, Faller, FES, SPDDS
0.24
SPDDS = Self-Assessment Parkinson’s Disease Disability Scale; TUG = Timed Up and Go test; CIRS = Cumulative Illness 
Rating Scale; FES = Falls Effi cacy Scale-International; H&Y = disease severity; UPDRS = Unifi ed Parkinson’s Disease 
Rating Scale (motor section); FOGQ = Freezing of Gait Questionnaire; MMSE = Mini Mental State Examination; Faller 
=≥1 fall in the preceding year versus no fall; HADS = Hospital Anxiety and Depression Scale.
TABLE 4.1
PERCENTAGE OF EXPLAINED VARIANCE (R2) OF A SELECTION OF MODELS
R2 Models
Models with three variables
0.21 8.6+0.71*Gender -0.078 * TUG -1.2*SPDDS
0.19 9.9+0.67*Gender -0.23*CIRS -1.6*SPDDS
11.3+0.65*Gender -0.024*Age -1.6*SPDDS
Models with four variables
0.22 8.5+0.74*Gender -0.20*CIRS -0.073*TUG -1.1*SPDDS
0.21 9.5+0.73*Gender -0.083 * TUG +0.16*FOGQ -1.5*SPDDS
9.6+0.71*Gender -0.016 * Age -0.068*TUG -1.2*SPDDS
8.9+0.68*Gender -0.097 * Education -0.080*TUG -1.2*SPDDS
8.3+0.75*Gender +0.18 * Marital Status -0.075*TUG -1.2*SPDDS
8.8+0.70*Gender +0.092 * HADS -0.078*TUG -1.3*SPDDS
8.6+0.71*Gender -0.099 * H&Y -0.072*TUG -1.1*SPDDS
8.4+0.71*Gender -0.077 * TUG +0.075*Faller -1.1*SPDDS
8.2+0.70*Gender +0.015 * MMSE -0.076*TUG -1.2*SPDDS
8.6+0.70*Gender -0.003 * UPDRS -0.075*TUG -1.1*SPDDS
8.7+0.72*Gender -0.075 * TUG -0.12*FES -1.1*SPDDS
TUG = Timed Up and Go Test; SPDDS = Self-Assessment Parkinson’s Disease Disability Scale; CIRS = Cumulative 
Illness Rating Scale; FOGQ = Freezing of Gait Questionnaire; HADS = Hospital Anxiety and Depression Scale; H&Y = 
disease severity; Faller = ≥1 fall in the preceding year versus no fall; MMSE = Mini Mental State Examination; UPDRS = 
Unifi ed Parkinson’s Disease Rating Scale (motor section); FES = Falls Effi cacy Scale-International.
TABLE 4.2
DETAILS OF SOME OF THE BEST-FITTING MODELS THAT DESCRIBE THE LEVEL OF PHYSICAL ACTIVITY
promotion of physical activity in parkinson's disease • the challenge to change behavior
56 57
multivariable analyses often have multiple solutions, all of which should be reported 0404
DISCUSSION
 In the literature, it is well-documented that multivariable regression analysis may result in several 
models that fit the data equally well.102-114 We illustrated this with an example based on a fairly 
large data set of 699 patients. While we used forward selection, other methods, including bac-
kward selection and hierarchical selection, will lead to similar results. 
 As some of the fourteen variables measured overlapping constructs, for example H&Y and 
UPDRS that both measure the severity of the disease, we repeated the analysis with seven inde-
pendent variables that mostly measure different constructs. However; this approach did not lead 
to a unique model either. 
 Apart from manually preselecting the variables that are included in the model selection proce-
dure, also statistical methods can be used, for example principal components analysis. However, 
whatever method is used to reduce the number of variables prior to the model selection, the 
results are often not unique and other variables or combination could have been chosen as well. 
Moreover, an elaborate search leading to an apparently unique solution may be misleading 
and appear to be a ‘fishing expedition’ for statistically pleasing results. The results of such an 
approach may even be less reliable than the results of a more straightforward approach.
 The purpose of our paper was neither to determine if multivariate regression leads to multiple 
solutions nor to show the best approach for variable selection. We wanted to illustrate that one 
model should not be solely reported as ‘the’ solution. When an analysis leads to multiple soluti-
ons, we propose that all models with approximately the same fit be reported. Therefore, we kept 
the analysis straightforward in this example. We presented an example of linear regression and 
used R2 as a criterion to select alternative models. In the case of logistic regression, a similar 
approach could be used with the Nagelkerke R2 or the c statistic as a criterion for model fit. The 
latter may be particularly useful when the aim of the study is to develop a diagnostic decision 
rule because the c statistic is equal to the area under the ROC curve.
 We propose that when variable selection is used to generate a multivariable regression model, 
the model should be analyzed to determine if it is unique and unambiguous. Additional models 
that fit the data equally well should be reported. Our proposal is based on two arguments. 
 First, a statistical analysis requires an estimate of its precision and reliability. For example, when 
an analysis estimates the difference between two means, one cannot conclude that this estima-
ted value is exactly the ‘true’ difference. Therefore, it is advisable to report a confidence interval. 
Confidence intervals contain all values for the difference that fit the data; one of those values is 
probably the ‘true’ value. When comparing two means, a 95% confidence interval may be re-
ported with a half width of approximately two times the standard error. Similarly, when the aim of 
an analysis is to obtain a multivariable model, not only a single result, but a range of models that 
fit the data should be reported. When the difference between two means is evaluated, a 95% 
confidence interval may be reported, with a half width of approximately two times the standard 
error. For multivariable models, the range of alternative models that should be presented is less 
obvious. In cases of linear regression, all models that have an R2 within two standard errors 
from the R2 of the best-fitting model could be reported. However, in our example, this approach 
would lead to 16 models with three variables and over 100 models with four variables. A stricter 
criterion that reports models with an R2 within one standard error would still lead to two models 
with three variables and approximately 40 models with four variables. In our analysis that utili-
zed seven variables, 14 models with three variables and 27 models with four variables had an 
R2 that was within two standard errors of the R2 of the best model. Hence, it may not always be 
feasible or even useful to present such an extensive list. However, it may be of interest to present 
additional models as additional information on the Internet.
 Our second argument for presenting all models with approximately the same fit is to improve 
systematic reviews. Presenting a range of results when no unique model is found may help when 
comparing and summarizing the results of different studies in systematic reviews. This strategy 
avoids unnecessary discussions about discrepancies between the results of studies, as a number 
of the models with a fit that is comparable to the best model may be similar across studies. The 
ranges of well-fitting models for studies presented in a systematic review could be compared in 
the same way as confidence intervals are compared in forest plots.
 In summary, several models seem appropriate to describe the relationship between the inde-
pendent factors and the physical activity level in patients with PD. We propose tables similar to 
Tables 4.1 and 4.2 to be included in the reports of multivariable analyses using variable selec-
tion methods. Such tables depict the uncertainty of results and avoid unnecessary discussions 
when other investigators find other models.
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ABSTRACT 
BACKGROUND
 Although physical activity is beneficial for Parkinson’s disease  patients, many do not meet the 
recommended levels. The range of physical activity among sedentary PD patients is unknown, 
as are factors that determine this variability. Hence, we aimed to (1) assess daily physical activity 
in self-identified sedentary PD patients; (2) compare this with criteria of a daily physical activity 
guideline; and (3) identify determinants of daily physical activity. 
METHODS
 Daily physical activity of 586 self-identified sedentary PD patients in the ParkFit study was mea-
sured with a tri-axial accelerometer for seven consecutive days. Physical fitness and demograp-
hic, disease-specific, and psychological characteristics were assessed. Daily physical activity 
was compared with the 30-minute activity guideline. A linear mixed-effects model was estimated 
to identify determinants of daily physical activity. 
RESULTS
 Accelerometer data of 467 patients who fulfilled all criteria revealed that >98% of their day was 
spent on sedentary to light-intensity activities. Eighty-two percent of the participants were ‘phy-
sically inactive’ (0 days/week of 30-minute activity); 17% were ‘semi-active’ (1-4 days/week of 
30-minute activity). Age, gender, physical fitness, and scores on the Unified Parkinson’s Disease 
Rating Scale explained 69% of the variability in daily physical activity. 
CONCLUSION
 Performance-based measurements confirmed that most self-identified sedentary PD patients are 
‘physically inactive’. However, the variance in daily physical activity across subjects was conside-
rable. Higher age, being female, and lower physical capacity were the most important determi-
nants of reduced daily physical activity. Future therapeutic interventions should aim to improve 
daily physical activity in these high-risk patients, focusing specifically on modifiable risk factors.
Physical activity, which includes exercise as well 
as daily physical activities,29 is important for pa-
tients with Parkinson’s disease. Although physi-
cal activity will not cure the disease, it may posi-
tively affect functional capacity, physical fitness, 
health, and several dimensions of quality of 
life.19 82 117 118-120 Recommendations state that PD 
patients should perform at least 30 minutes of 
physical activity (≥ moderate intensity) per day 
(in bouts of minimal 10 minutes). This should be 
done for at least five days per week.121 
Research suggests that many PD patients do 
not meet this recommendation.19 31 115 122 123 
However, it is not clear how far the actual dai-
ly physical activity of patients is below the rec-
ommended level, what the range in physical 
activity is across patients, and which factors 
determine differences in daily physical activ-
ity across patients. This is important to know, 
because it could have implications for the 
way physical activity levels can be enhanced. 
A number of related factors have been sug-
gested in the literature to account for differ-
ences, including disease-related features,31 115 
demographics, psychological characteristics 
and physical fitness.32 115 124 125 
However, it remains unknown how these factors 
specifically contribute to the variability in daily 
physical activity among PD patients who do not 
meet the recommended level of physical activity. 
PD patients below the recommended level of 
daily physical activity were included in the Park-
Fit study, a randomized controlled trial that ex-
amined the effects of a multifaceted behavioral 
program on physical activity behavior.42  This 
screening was initially done with a specifically 
developed questionnaire. Subsequently, actual 
daily physical activity was quantified with an ac-
celerometer. Compared to questionnaires, such 
performance-based measurements can provide 
more accurate and detailed information about 
the diversity, duration, and intensity of physical 
activities during the day.
The primary aim of this study was to produce for 
the first time a performance-based description of 
daily physical activity in self-identified sedentary 
PD patients. Second, by comparing these results 
with criteria of the daily physical activity guide-
line,121 we examined whether these patients were 
really ‘physically inactive’ (in the sense of failing 
to meet the recommended level of physical activ-
ity once a week) or ‘semi-active’ (in the sense of 
meeting the recommended level of physical activ-
ity one to four days per week).21 Third, we aimed 
to identify determinants of daily physical activity 
in these patients. 
INTRODUCTION  
METHODS
STUDY DESIGN
 All subjects in the present study are participants in the ParkFit trial,42 and their baseline data 
were used here. The ParkFit trial is a multicenter, randomized controlled trial whose aim is to 
increase physical activity levels in sedentary PD patients.42 The study complied with principles 
outlined in the Declaration of Helsinki and was approved by the local ethics committee. All 
participants gave their written informed consent.
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STUDY SAMPLE
 The ParkFit trial recruited patients from 32 community hospitals between September 2008 
and January 2010. All of these patients had received chronic care from a neurologist. Patients 
were included if they were diagnosed with idiopathic PD,2 were rated with a Hoehn and Yahr 
(HY) stage ≤3,126 and were between 40 and 75 years of age. Also, to be included candidate 
subjects had to report that they do not meet the recommended level of daily physical activity 
(i.e.,moderate-intensity physical activity for >150 minutes for >3 times/week or vigorous-inten-
sity physical activity for >60 minutes for >3 times/week15). Included PD patients are referred to 
throughout this study as being ‘self-identified sedentary’ to make it clear that their initial status 
was determined by perceived daily physical activity, not objectively measured activity. Exclusion 
criteria concerned marked cognitive impairment (Mini-Mental State Examination [MMSE] score 
of <24),127 unability to complete Dutch questionnaires, severe comorbidities that interfered with 
daily functioning, receiving daily institutionalized care, and previously deep brain surgery. 
MEASUREMENTS
 Demographic and disease-specific characteristics 
 Demographic and disease-specific characteristics were assessed with self-report questionnaires 
and by trained assessors. The modified HY scale,126 and the motor part of the Unified Parkinson’s 
Disease Rating Scale (UPDRS)58 were used to assess the severity of the disease. Cognition was 
measured with the MMSE.127
 Daily physical activity
 Daily physical activity was performance-based measured with a tri-axial accelerometer for 
movement registration (TracmorD, Philips New Wellness Solutions, Lifestyle Incubator, The 
Netherlands). This small device can be worn as a necklace, attached to a belt, or in a pocket. 
It converts activity counts via algorithms into energy expenditure in kcal per minute. It is a valid 
device for predicting energy expenditure in daily life, with correlations with the doubly labeled 
water technique ranging from .54 to .91.88 128 129  Although the accelerometer was not specifically 
validated for PD patients, no extensive problems with validity in this specific population were 
expected. No unambiguous evidence exists to indicate that patients expend more energy than 
healthy subjects to achieve the same movements, or that patients’ resting energy is elevated.46 130 
 Several literature-based decisions were made with regard to preprocessing the accelerometer 
data.131 Patients were asked to wear the accelerometer every day for a period of two weeks, a ‘day’ 
being 24 hours. ‘Non-wearing time’ was defined as a period of at least 60 consecutive minutes of 
zero’s, with a maximum of 2 minutes larger than 0.2 kcal.67 132 Subtracting non-wearing time from 
24-hours resulted in the ‘wearing time’. To determine the minimal wearing time per day acceptable 
for a valid measurement, we  used the ‘70/80’ rule.67 131 133 A measurement was deemed valid if the 
patient wore the accelerometer for at least 80% of the ‘wearing day’. ‘Wearing day’ was defined 
as the length of time in which at least 70% of the subject sample was wearing the accelerometer. 
Only the last seven consecutive valid days were included for data analysis.  
 Daily physical activity was expressed as mean total energy expenditure per day (in kcal), which 
was calculated by dividing the sum of energy expenditure (in kcal) of the last seven consecutive 
valid days by seven for each participant. This consisted of sedentary to light-intensity activities 
(0-3.5 kcal/minute), moderate-intensity activities (3.5-7 kcal/minute), and vigorous-intensity ac-
tivities (>7 kcal/minute) per day.134
 Psychological characteristics
 Depression and generic anxiety were measured with the Hospital Anxiety and Depression Scale 
(HADS).60 135 The scale consists of two subscales (depression and anxiety), which have seven 
items each. Scores on the subscales range from 0 to 21; higher scores indicate more symptoms. 
 Only patients who were randomized to the intervention group (N=299) of the original ParkFit 
trial42 completed the Self-Efficacy for Exercise Scale (SEE),136 which assessed their self-efficacy 
toward physical activity. The SEE consists of nine items that rate the degree of confidence in per-
forming regular physical activity across a range of circumstances (range: 0-10). A higher score 
indicates a higher level of exercise self-efficacy. 
 Physical fitness
 Physical fitness was measured with the 6-minute walk test (6-MWT).137 138 This submaximal test 
measures the distance (in meters) a patient is able to walk for a period of 6 minutes. 
DATA ANALYSIS
 Descriptive statistics were used to characterize the participants and their daily physical activity 
outcomes. To calculate prevalence rates for physically active, semi-active and physically inactive 
patients,21 121 we collected data on the patients’ daily physical activity. The activity had to be 
(1) performed for at least 10 consecutive minutes, with allowable interruptions of maximally 2 
minutes131; and (2) either moderate intensity (3.5-7 kcal/minute) or vigorous intensity (> 7 kcal/
minute).134 Patients were classified as ‘physically active’ if they were physically active for a mini-
mum of 30 minutes/day (in bouts of ≥ 10 minutes), if the intensity of the activity was moderate 
or vigorous, and if they performed this activity for a minimum of 5 days/week. Patients were 
classified as ‘semi-active’ if they were moderately to vigorously active (30 min/day) for 1-4 days/
week, and as ‘physically inactive’ if they were active for zero days/week. For exploratory reasons, 
we calculated prevalence rates based on the total number of minutes of moderate- to vigorous-
intensity activities per day for  ‘physically active’, ‘semi-active’ and ‘physically inactive’ patients. 
Average bout-length was assessed as well. 
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 The fi rst step for identifying determinants of daily physical activity was to calculate correlations 
(Spearman’s rho) between mean total energy expenditure and demographics, disease-specifi c 
characteristics, physical fi tness and psychological characteristics. The second step was to ana-
lyze differences in mean total energy expenditure between men and women, HY stages, and 
education levels by using Mann-Whitney/Kruskall Wallis tests. The fi nal step was to fi t a linear 
mixed-effects model by using maximum likelihood.  All analyses were performed in the statistical 
programming language R and SPSS (17.0); p-values of <0.05 were considered signifi cant.
RESULTS
STUDY SAMPLE
 Of the 3453 PD patients who were invited to participate in the ParkFit trial, 1766 were excluded. 
Of those excluded, 1263 did not qualify because they met or exceeded the physical activity 
guideline. Of the remaining 1687 eligible patients, 1101 were not willing to participate.42 In 
total 586 were randomized into the ParkFit trial. Of these, 119 patients (20%) were excluded 
from the present study based on accelerometry-data preprocess decisions (see Methods). In 
total, 467 patients (80%) had valid accelerometry measurements (≥659 minutes/day) on at least 
seven consecutive days. There were no signifi cant differences in age (Mann-Whitney U=26388; 
p=.40); gender (Chi²=1.44; p=.23); body mass index (BMI) (Mann-Whitney U=27292; p=.76); 
HY stage (Chi²=1.82; p=.77); or disease duration (Mann-Whitney U= 27186; p=.72) between 
patients with insuffi cient (<7 valid days) and suffi cient (≥7 valid days) accelerometer data. Patient 
characteristics of the study sample (N=467) are presented in Table 5.1. 
DESCRIPTION OF PERFORMANCE-BASED DAILY PHYSICAL ACTIVITY
 The median (IQR) time PD patients wore the accelerometer was 997 (234) minutes/day (16.6 
hours/day). The median (IQR) of the mean total energy expenditure per day was 463.8 kcal (271.7). 
Figure 5.1 presents a histogram of the distribution of the mean total energy expenditure from the 
study sample as well as the estimated density for the total population. This fi gure shows a relati-
vely large variance in daily physical activity within the sample of self-identifi ed sedentary patients.
 
q
Patient characteristics (n=467) 
Demographic characteristics
Age (years) Median (IQR) 67.0 (10.0)
Mean (SD) 65.7 (7.4)
Gender
Men Number (%) 310 (66%)
Women Number (%) 157 (34%)
BMI Median (IQR) 27.1 (5.1)
             Mean (SD) 27.6 (4.3)
Overweight (BMI 25-30) Number (%) 228 (49%)
Obesity (BMI >30) Number (%) 108 (23%)
Spouse
Yes Number (%) 399 (86%)
No Number (%) 67 (14%)
Education
Low Number (%) 272 (58%)
High Number (%) 195 (42%)
Disease speciﬁ c characteristics
Time since diagnosis (months) Median (IQR) 44.0 (67.0)
Mean (SD) 61.8 (52.6)
Hoehn & Yahr stage
1 Number (%) 8 (2%)
1.5 Number (%) 14 (3%)
2 Number (%) 350 (75%)
2.5 Number (%) 69 (15%)
3 Number (%) 26 (6%)
UPDRS III (0-108) Median (IQR) 32 (13)
Mean (SD) 32.9 (10.5)
Daily Levodopa equivalent dose (mg) Median (IQR) 417.9 (402.0)
Mean (SD) 480.0 (389.7)
Psychological characteristics
Cognition (MMSE 0-30) Median (IQR) 28.0 (2.0)
Mean (SD) 28.1 (1.7)
Anxiety (HADS 0-21) Median (IQR) 5.0 (4.0)
Mean (SD) 5.3 (3.4)
Depression (HADS 0-21) Median (IQR) 4.0 (5.0)
Mean (SD) 4.8 (3.6)
Self-efﬁ cacy (SEE 0-10) (N=168) Median (IQR) 5.4 (2.2)
Mean (SD) 5.4 (1.5)
Physical ﬁ tness
6-MWT (in meters) Median (IQR) 400.0 (100.0)
Mean (SD) 394.6 (85.2)
TABLE 5.1
PATIENT CHARACTERISTICS
 Continuous variables were not normally distributed, except for self-effi cacy. ADL, Activities of Daily Living; BMI, 
Body Mass Index; HADS, Hospital Anxiety and Depression Scale; IQR, interquartile range, MMSE=Mini-Mental 
State Examination; SD, standard deviation; SEE, Self-Effi cacy for Exercise Scale; UPDRS-III, Unifi ed Parkinson’s 
Disease Rating Scale, motor part; 6-MWT, 6 Minute walk test. 
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A. Distribution of daily physical activities*
Sedentary to light-
intensity activities
Moderate-intensity 
activities
Vigorous-intensity 
activities
Energy expenditure 
(kcal/day)    
Median (IQR) 385.9 (168.2) 46.2 (97.5) 2.1 (18.4)
Mean (SD) 414.7 (147.5) 68.0 (76.5) 27.5 (63.8)
Time spent (min/day) Median (IQR) 978.6 (248.9) 10.7 (20.0) 1.4 (2.3) 
Mean (SD) 1026.0 (172.0) 14.6 (15.9) 3.2 (7.2)
Percentage of day Median (IQR) 99.0% (2.5%) 0.9% (2.0%) 0.02% (0.2%)
Mean (SD) 98.3% (2.1%) 1.4% (1.6%) 0.3% (0.7%)
B. Classiﬁ cation according to the physical activity guideline**
Physical activity at ≥ moderate intensity, 
accumulating..
Physically inactivea Semi-activeb Physically-activec
..10-min bouts N(%) 383 (82%) 81 (17.3%) 3 (0.6%)d
..every minute N(%) 250 (53.5%) 148 (31.7%) 69 (14.8%)
*Median (IQR) measured time= 997 (234) minutes/day (16.6 hours/day); **Thirty minutes/day physically active at ≥ 
moderate intensity for ≥5 days/week; aMinimum of 30 minutes of moderate- to vigorous-intensity physical activity for 
zero days; bMinimum of 30 minutes of moderate- to vigorous-intensity physical activity for 1-4;  cMinimum of 30 minutes 
of moderate- to vigorous-intensity physical activity for 5 or more days; dRecommended level of physical activity; IQR, 
Interquartile range; SD, standard deviation; kcal, kilocalories.
TABLE 5.2
DISTRIBUTION OF DAILY PHYSICAL ACTIVITIES AND CLASSIFICATION ACCORDING TO PHYSICAL ACTIVITY 
GUIDELINE (N=467)
 Mean total energy expenditure was categorized according to the intensity of physical activity: se-
dentary to light, moderate, and vigorous intensity (Table 5.2). The median time spent on physical 
activities at a minimum of moderate intensity was approximately 12 minutes/day (≈1% of mea-
sured time). With regard to moderate- to vigorous-intensity physical activities, the median of the 
average bout length was 1.6 minutes. The median of the maximum bout length was 6 minutes. 
Sixty percent of the participants failed to achieve an activity session of at least 10 minutes. 
ACTUAL DAILY PHYSICAL ACTIVITY COMPARED TO THE PHYSICAL ACTIVITY GUIDELINE
 Eighty-two percent of the participants were classifi ed as physically inactive, and 17.3% as semi-
active (Table 5.2). Prevalence rates differed when it was based on the total number of minutes 
of moderate- to vigorous-intensity activity, rather than on the recommended 10-minute bouts 
of activity: 53.5% of the patients were categorized as physically inactive, 31.7% as semi-active, 
and 14.8% as physically active.
FIGURE 5.1
DISTRIBUTION OF MEAN TOTAL DAILY ENERGY EXPENDITURE IN KCAL/DAY (N=467), WITH DENSITY 
ESTIMATION FOR TOTAL POPULATION (MEDIAN= 463.8 KCAL/DAY, WHITE VERTICAL LINE) 
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Mean total energy expenditure per day
Spearman’s rho P value
Age (years) -.34 <.001**
BMI -.11 .019*
UPDRS, motor function -.26 <.001**
Time since diagnosis (months) -.03 .530
Daily Levodopa equivalent dose (mg) .07 .142
Cognition (MMSE) .12 .007**
Anxiety (HADS-A) .08 .090
Depression (HADS-D) -.01 .873
Self-efﬁ cacy (SEE) .08 .263
Physical ﬁ tness (6-MWT) .38 <.001**
BMI, body mass index; UPDRS, Unifi ed Parkinson’s Disease Rating Scale; MMSE, Mini-mental state examination; 
HADS, Hospital Anxiety and Depression Scale; SEE, Self-Effi cacy for Exercise Scale; 6-MWT, 6-Minute walk test.
 * Correlation is signifi cant at the 0.05 level (two-tailed); ** Correlation is signifi cant at the 0.01 level (two-tailed).
Fixed effects  95% CI
Value SE T P value Lower Upper 
Constant 868.43 119.45 7.27 <.001 634.39 1102.48
Age (years) -6.70 1.30 -5.17 <.001 -9.26 -4.15
Gender (0=male; 1=female) -60.95 20.36 -2.99 .003 -100.93 -20.98
Distance at 6-MWT (m) .46 .13 3.61 <.001 .21 .70
UPDRS, motor function (0-108) -2.32 .94 -2.47 .014 -4.16 -.47
Within group standard error 149.21 145.32 153.21
* Dependent variable was mean total energy expenditure in kcal/day. SE, Standard error; 6-MWT, 6-Minute walk test; 
UPDRS, Unifi ed Parkinson’s Disease Rating Scale.
TABLE 5.3
 CORRELATIONS WITH MEAN TOTAL ENERGY EXPENDITURE PER DAY
TABLE 5.4
LINEAR MIXED-EFFECTS MODEL* 
DETERMINANTS OF DAILY PHYSICAL ACTIVITY
 As presented in Table 5.3, age, BMI, and the motor part of the UPDRS were negatively corre-
lated to mean total energy expenditure (p<0.05). Cognition and physical fi tness were positively 
correlated to mean total energy expenditure (p<0.01). Men (mean [SD] 541.9 [209.7] kcal/day) 
were more physically active than women (mean [SD]447.6 [198.8] kcal/day) (Mann-Whitney U 
= 16825.0; p<.001). Patients with a spouse (mean [SD] 524.1 [213.4] kcal/day) were more phy-
sically active than those without a spouse (mean [SD] 429.3 [174.8] kcal/day) (Mann-Whitney U 
= 9441.0; p<.001). Patients with more severe PD (higher HY stage) were less physically active 
than patients with less severe PD (lower HY stage) (Chi2=12.4; p=.002). 
 To estimate a linear mixed-effects model for predicting mean total energy expenditure, we used 
variables that were signifi cantly different in mean total energy expenditure (gender, spouse, HY) 
and variables that were signifi cantly correlated to mean total energy expenditure (age, BMI, 
UPDRS, MMSE and distance on the 6MWT). The best model found according to minimum 
Akaike information criterion (AIC) had all coeffi cients signifi cant, including age, gender, dis-
tance on the 6-MWT, and the motor part of the UPDRS (R2=0.69) (Figure 5.4). 
DISCUSSION
 The present study demonstrates that daily physical activity of self-identifi ed sedentary PD pa-
tients varies widely, but the majority of their time is associated with sedentary to light-intensity 
physical activities. Using a performance-based assessment of daily physical activities, we report 
for the fi rst time that most self-identifi ed sedentary PD patients (82%) can indeed be classifi ed 
as physically inactive and a smaller proportion (17%) as semi-active. Higher age, being female, 
more motor problems, and less physical fi tness were the most important determinants of reduced 
daily physical activity.
 Variability in daily physical activity is always present to a greater or lesser extent both in healthy 
adults and in chronically ill patients.139 Our results show that, even among a selected subca-
tegory of self-identifi ed sedentary PD patients, however, the variability in daily physical activity 
is still considerable. Although the majority (82%) failed to meet the daily recommended level 
of 30 minutes activity, even for one day per week, some (17%) did achieve the recommended 
level for one to four days per week. This suggests that even self-identifi ed sedentary PD patients 
are capable of performing at least some physical activity. This is important new information for 
designing physical activity promotion programs for inactive PD patients. Even if these patients 
cannot meet the recommended level of physical activity, some activity is still considered to be 
better than none.140 
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 The results of our study show that performing moderate-intensity activity for a minimum of 10 
consecutive minutes was problematic for self-identified sedentary PD patients; the median length 
of their activity sessions was only 1.6 minutes. The majority (61%) of our participants failed to 
perform a single 10-minute session in a week. When data were collected on each minute of 
activity performed at a moderate to vigorous intensity, we found that more patients (46.5%) per-
formed 30 minutes of activity per day than when data were collected on only 10-minute sessions 
of activity (18%). Further research should clarify whether 10-minute bouts (which are currently 
recommended) are really necessary to produce health effects in PD patients. 
 The present study showed that self-identified sedentary PD patients spent the largest part of 
their day engaging in sedentary to light-intensity physical activities (98.3%). This is in line with 
another study showing that patients with advanced PD were sedentary (lying/sitting) for 76.7% of 
the time.47 Also healthy adults and older people have been shown to spend most of their day on 
sedentary to light-intensity physical activities.141 The pattern of sedentary behavior in PD patients 
might be different, however, compared to that of healthy adults.47 The participants in the present 
study spent only 1% of the measured time on activities performed at a moderate to vigorous in-
tensity, which translates to approximately 12 minutes per day. This is comparable to patients with 
chronic obstructive pulmonary disease (COPD); COPD patients spent, on average, 7.0-13.2 
minutes per day performing moderate- to vigorous-intensity physical activities.142 By contrast, 
healthy adults perform moderate-intensity activities for 34 minutes per day, on average, or 17 
minutes per day when bouts of minimally 10 minutes are taken into account.141 
 Daily physical activity in self-identified sedentary PD patients is associated with several factors. Our 
findings corroborate those resulting from the survey of Bauman et al. (2002), who summarized 
factors often associated with physical activity.125 Higher age, higher BMI, and more motor problems 
were associated with less daily physical activity, as was gender (females), lacking a spouse, and se-
vere disease. Conversely, better cognition and higher levels of physical fitness were associated with 
more daily physical activity. Our results showed that the variability in daily physical activity was mainly 
explained by age, gender, motor problems and physical fitness. The linear mixed-model showed that 
as age increases by one year, daily physical activity decreases by 6.7 kcal per day. Women spent 
61.0 kcal/day less on daily physical activities than men. One point higher on the motor part of the 
UPDRS results in a decrease of 2.3 kcal/day spent on daily physical activities. An improvement of one 
meter on the 6MWT results in an increase in daily physical activity of 0.5 kcal/day.
 In other patient populations (e.g., heart failure patients143 and candidates for lung transplanta-
tion144), physical fitness is also an important predictor of daily physical activity. Our findings illus-
trate that daily physical activity is related in part to factors that cannot be changed (age, gender), 
but also in part to factors that are modifiable (physical capacity such as motor problems and 
physical fitness). Several studies show that the physical capacity of PD patients can be improved 
by exercise. For example, an 8-week pole-striding exercise program can improve motor pro-
blems in PD patients.120 Furthermore, physical exercise improves aerobic capacity, muscular 
strength, balance, gait, physical performance and activities of daily living.82 123 However, more 
research is needed to support the suggestion that these improvements lead to actual increase in 
daily physical activities, because the direction of the relationship between physical capacity and 
daily physical activity could not be defined based on our results. 
 When interpreting the present results, it should be noted that only self-identified sedentary pa-
tients were included. Therefore, the results may not be representative of the total PD population. 
In addition, approximately 65% of the self-identified sedentary patients were reluctant to parti-
cipate in the ParkFit trial, possibly introducing selection bias. Since the present study used the 
baseline data of the ParkFit trial, daily physical activity of reluctant patients was not part of our 
analysis. Finally, due to the relatively small sample size, caution must be taken in generalizing 
the results of this study to all sedentary PD patients.  
CONCLUSION
 Self-identified sedentary PD patients spent the majority of their time being sedentary or perfor-
ming light-intensity physical activities. The variability in physical activity is considerable and can 
be, in part, explained by age, gender, and physical capacity. Higher age, being female, having 
more motor problems, and being less physically fit are the most important determinants of re-
duced daily physical activity. Age and gender cannot be modified by experimental intervention, 
but physical capacity can. We suggest that future therapeutic interventions aim to improve daily 
physical activity in these high-risk patients by focusing, in particular, on modifiable risk factors. 
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ABSTRACT
BACKGROUND
 The sedentary lifestyle of patients with Parkinson’s disease (PD) adversely affects their health. 
Reversing this lifestyle is difficult because of combined physical and cognitive handicaps that are 
intrinsic to PD. Here, we evaluate whether a multifaceted behavioral change program increases 
physical activities in PD.
METHODS
 We performed a multicenter, randomised controlled trial to increase physical activity levels in 
sedentary PD patients. Patients were randomly assigned to the ParkFit program or a matched 
general physiotherapy intervention. ParkFit is a multifaceted behavioral change program, de-
signed specifically to achieve an enduring increase in the level of physical activity program 
(coaches using motivational strategies; ambulatory feedback). Primary endpoint was the level 
of physical activity, measured every six months using a standardized 7-day recall (LASA Physical 
Activity Questionnaire, LAPAQ). Secondary endpoints included two other measures of physical 
activity (activity diary; and ambulatory activity monitor), quality of life (PDQ-39), and fitness 
(6-minute walk test).
RESULTS
 586 sedentary patients with idiopathic PD between 40 and 75 years with mild to moderate 
disease severity (Hoehn and Yahr stage ≤3) were randomized; 540 patients (92.3%) completed 
the primary outcome. During follow-up, overall time spent on physical activities was comparable 
between both groups (adjusted group difference 7%; 95% CI -3 to 17%; p=0.19). Analyses of 
three secondary outcomes indicated increased physical activity in ParkFit patients, as suggested 
by the activity diary (difference 30%; p<0.001), the activity monitor (difference 12%; p<0.001), 
and 6-minute walk test (difference 4.8 meters; p=0.05). PDQ-39 did not differ between ParkFit 
and controls (difference -0.9 points; p=0.14). The number of fallers was comparable between 
ParkFit (62%) and controls (67%). 
CONCLUSION 
 The ParkFit behavioral change program did not increase overall physical activity, as measured 
with the LAPAQ. The analysis of the secondary endpoints justifies further work into the possible 
merits of behavioral change programs to increase physical activities in daily life.
INTRODUCTION  
Parkinson’s disease (PD) is a common neuro-
degenerative disease, characterized by motor 
symptoms2 and a wide variety of non-motor 
symptoms like depression or apathy.3 Despite 
optimal medical treatment, PD remains a pro-
gressive disease that negatively affects quality 
of life. Therefore, allied health interventions are 
increasingly deployed to treat both the motor 
and non-motor symptoms of PD. The evidence 
to support the merits of these interventions is 
growing, and treatment guidelines (based par-
tially on evidence, and partially on practical 
clinical experience) for several allied healthcare 
interventions have been developed.6 7 11
In recent years, a number of physiotherapy 
programs have been tested in patients with 
PD.145-149 Reviews and meta-analyses gener-
ally found evidence to support ‘exercise’ as 
being beneficial with regard to physical func-
tioning, strength, balance and gait speed.25 77 
150-152 However, the physiotherapy programs as 
tested in these studies were apparently insuf-
ficient to achieve an active lifestyle. Indeed, 
because of their combined physical limitations 
and mental changes, many PD patients lead 
a sedentary lifestyle.115 Reversing this lifestyle 
could have generic health benefits, including 
increased survival.14 17 18 Promoting physical 
activity may also improve specific symptoms 
of PD, such as insomnia, depression or con-
stipation.19 Furthermore, rodent work suggests 
that physical activity might counter neurode-
generation in experimental parkinsonism.76 84
An individually tailored, disease-specific train-
ing program is needed to improve physical ac-
tivity in PD.15 We developed such an interven-
tion (the ParkFit program42) based on models 
of behavioral change33 34 and containing es-
tablished behavioral change techniques.35 38 
41 To evaluate this program, we designed a 
randomized controlled trial (RCT) comparing 
ParkFit with a matched control intervention.42 
METHODS
 The ParkFit trial is a multicenter RCT to increase physical activity levels over the course of two 
years in sedentary PD patients. The study design has been detailed elsewhere.42 
STUDY PARTICIPANTS
 Recruitment ran from September 2008 to January 2010. Patients treated in 32 community 
hospitals were invited to participate. Eligibility criteria were: (a) PD according to UK Brain Bank 
Criteria2; (b) age 40–75 years; (c) sedentary lifestyle, defined as: participation in vigorous-
intensity physical activity <3 times a week, and for <60 minutes in total per week; or participa-
tion in moderate-intensity physical activity <3 times a week, and for <150 minutes in total per 
week15; and (d) Hoehn and Yahr stage ≤3. Exclusion criteria were: (a) MMSE <24; (b) unable to 
complete Dutch questionnaires; (c) co-morbidity that interfered with daily functioning; (d) daily 
institutionalized care; and (e) previous deep brain surgery. The protocol was approved by the 
local ethics committee. Informed consent was obtained before the first assessment.
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STUDY OUTCOMES
 Baseline characteristics
 Disease stage was scored according to the modified Hoehn and Yahr scale. Motor function was 
assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS part III, motor examination).
 
 Primary endpoint 
 Several amendments were made in the initial phase of the study, at a time when recruitment 
was underway for only two months. We here report our final selection of endpoints, as specified 
on ClinicalTrials.gov, in the adapted final research protocol that was accepted by the Ethical 
Committee (CMO) Arnhem Nijmegen and in a recent design article.42 
 Primary endpoint was the LASA Physical Activity Questionnaire (LAPAQ), a validated interview-
based 7-day recall of physical activities. The LAPAQ was highly correlated with a 7-day diary 
(r = 0.68, P<.001), and moderately with a pedometer (r = 0.56, P<.001). 55 LAPAQ asks 
patients about their daily amount of specific activities, allowing for calculation of total time spent 
on physical activities (expressed in hours per week). LAPAQ covers the frequency and duration 
of the net sum of the following activities: walking outdoors, cycling, gardening, light and heavy 
household activities and sport activities.55 Consequently, higher scores on the LAPAQ (in hours 
per week) indicated more time spent on physical activity. LAPAQ was measured at baseline, and 
after 6, 12, 18 and 24 months. At baseline, and after 12 and 24 months, LAPAQ was completed 
during face-to-face interviews; after six and 18 months, LAPAQ was completed by telephone. 
We assumed that patients would increase their level of physical activity during the first months 
of the intervention, and would then maintain this level. Therefore, the main endpoint was the 
average of the level of physical activity during the entire follow-up period (i.e. average of 6, 12, 
18 and 24 months). This approach has several advantages. First, it provides a global assessment 
of the results of the intervention. Second, it provides maximal power. As the number of assess-
ments that is taken into account increases, so does the power. We did not compare all individual 
time points (at 6, 12, 18 and 24 months) separately, because this leads to multiplicity.
 Secondary endpoints 
 We defined four secondary endpoints:42 (1) physical fitness, as measured with the 6-minute walk 
test95 at 12 and 24 months (i.e. average of all measurements); (2) quality of life, as measured 
with the PDQ-39153 at 6, 12, 18 and 24 months (i.e. average of all measurements); (3) physical 
activity, measured subjectively every six months with a 7-day activity diary (i.e. average of all 
measurements);68 and (4) physical activity, measured objectively every six months with an ambu-
latory activity monitor (i.e. average of all measurements).88 
 The diary detailed the frequency and total duration (hours/week) spent on five specific activities: 
walking outdoors for >10 contiguous minutes; moderate-intensity cycling for >10 contiguous 
minutes; high-intensity cycling for >10 contiguous minutes; sport activities; and other strenuous 
activities (e.g. cutting wood). The activity monitor (triaxial accelerometer)88 was worn as a nec-
klace, on the belt or in the pocket. Data were collected during waking hours for 14 days and 
were stored minute by minute for each axis; output was expressed in kilocalories/minute. Only 
completely observed days were included in the analysis.133 The monitor was additionally used 
as feedback-tool by patients allocated to the ParkFit program, using light-emitting diodes that 
reflected the amount of actually delivered daily physical activity. Control patients received no 
feedback of their activity monitor.
 Safety and falls
 Safety was assessed by spontaneous reports of adverse events. Serious adverse events were 
classified as events that caused death, were life-threatening, or necessitated hospital admis-
sion. Falls were monitored monthly with an automated telephone system.154 Information about 
adverse events was additionally collected at each physical assessment.
INTERVENTION  
 After baseline assessment, patients were randomly assigned to either the ParkFit program or a 
matched physiotherapy intervention aimed at safety of movements. The investigators logged 
in on a protected website and entered region, Hoehn & Yahr stage, age, gender and current 
physical activity level of the patients. Based on a minimization algorithm with these factors, the 
treatment was allocated and registered. Before inclusion, patients were informed that the trial 
compared two potentially beneficial interventions. We used ‘active’ names for both interventions 
(‘ParkFit’ and ‘ParkSafe’ program). To ensure blinding, patients were examined by trained asses-
sors who were unaware of group allocation. Patients were instructed not to discuss the nature of 
their physiotherapy with the assessors.
 Both interventions were delivered solely by experienced physiotherapists in the Dutch 
ParkinsonNet.13 In total, 154 physiotherapists were trained to deliver both interventions. This 
ascertained that differences in personality or style of the physiotherapists could not bias the 
results. All patients were offered an equal maximum number of treatment sessions (35/year). 
The full study protocol has been detailed elsewhere.42
 ParkFit program
 The ParkFit program was designed specifically to achieve a sustained increase in physical acti-
vity levels, based on theories and models of behavioral change33 34 and on effective behavioral 
change techniques.35 38 41 Important elements were: (a) activity coaches, who guided each pa-
tient towards a more active lifestyle during monthly personal coaching sessions; (b) educatio-
nal brochure about the benefits of physical activity and suitable activities for PD patients; (c) 
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identifying and overcoming any perceived barriers to engage in physical activity; (d) systematic 
goal setting, using a health contract and logbook; (e) stimulation to participate in group exercises; 
and (f) ambulatory monitor with automated feedback reflecting actually delivered physical activi-
ties.88 Ambulatory monitor data were uploaded to a personalized website, where both the patient 
and coach could monitor progress.
 The ParkFit program also included regular physiotherapy sessions. Based on individual disabilities, 
the therapist and patient jointly formulated individually tailored treatment aims, according to the 
evidence-based guideline of physiotherapy for PD.11
 Control intervention
 The control intervention consisted of a general physiotherapy program aimed at safety of move-
ments, according to the evidence-based guideline.11 Patients received an identical brochure as 
ParkFit patients, but now with information about the benefits of physiotherapy and safety of move-
ments. Patients were offered a maximum number of treatment sessions, similar to the ParkFit 
program. An active lifestyle was not explicitly stimulated. Treatment aims were jointly formulated 
by therapist and patient, based on perceived individual disabilities.
STATISTICAL ANALYSIS 
 Main endpoint was the physical activity level during the entire follow-up (6, 12, 18 and 24 months). 
Because the physical activity level was skewed, medians and interquartile ranges were presented, 
and analyses were performed after logarithmic transformation. Differences between both inter-
ventions were evaluated using a linear mixed model with random nested factors ‘patient’ and 
‘exercise group’. Region, Hoehn & Yahr stage, age, gender and current physical activity level of the 
patients were included as co variables. Results were analyzed according to a modified intention-
to-treat principle, whereby only patients that had no follow-up measurements at all were excluded.
 Sample size calculation
 Based on the following power considerations, we aimed to include a total of 700 patients. In a 
small observational study on physical activity in PD, patients scored 45% less on the LAPAQ com-
pared to controls (unpublished data). The coefficient of variation was 110%. Based on a difference 
of 20% in hours per week (with coefficient of variation of 110%) between both treatment arms, the 
mixed model analysis will have at least 80% power (when the correlation between baseline and 
follow-up measurements is at least 0.50, and when the correlation between the various follow-up 
measurements is at most 0.75). The decision to define a 20% increase based on the LAPAQ activity 
as a clinically relevant difference was a pragmatic choice, because there were no earlier inter-
vention studies that aimed to change activity behavior in Parkinson’s disease patients. Moreover, 
prior behavioral change studies in other diseases (e.g. heart failure, diabetes and COPD) did not 
include the LAPAQ as an endpoint. In an earlier study by our group 115, we found that PD patients 
were 29% less active compared to controls (as measured with the LAPAQ): patients spent 12.9 
hours per week on physical activity, while controls spent more than 17.5 hours. We deemed 
an increase in physical activity among PD patients of more than four hours unrealistic, and 
reasoned that an increase of two hours per week (i.e. an increase of about 20%) would be fea-
sible. We also considered a 2-hour increase in physical activity to be clinically relevant, for the 
following reasons. A dose-response relation exists between physical activity and cardiovascular 
disease or premature mortality.50 Significant risk reductions have been observed with 45-150 
minutes/week of brisk walking.155 Additionally, women who walked or exercised vigorously for 
at least 2.5 hours/week had a 30% lower risk of coronary heart disease.155 Conversely, the risk 
of cardiovascular disease was higher among women who spent >12 hours/day lying down or 
sleeping.155 This suggests that a 2-hour increase in physical activities might help to prevent car-
diovascular disease. The power is based on two sided 95% confidence intervals. We assumed 
that the clustering due to the fact that the intervention was carried out in training groups of ap-
proximately eight patients leads to an ICC of 0.1. Based on a previous trial of physical therapy 
in PD,13 we expected a drop-out rate of 10%.
RESULTS
BASELINE CHARACTERISTICS
 586 patients were included (Figure 6.1). 299 patients were randomly assigned to the ParkFit 
program, and 287 to the control intervention. Both groups had comparable demographic and 
disease characteristics, although ParkFit patients tended to be less active in daily life (i.e. less 
time spent on physical activity in hours per week, based on LAPAQ) than controls (Table 6.1). 
LOST TO FOLLOW-UP 
 540 of the 586 participants (92.3%) completed the LAPAQ after 24 months. The proportion of 
patients lost to follow-up was comparable for ParkFit (8.7%) and controls (6.7%). Patients lost to 
follow-up were similar to those who completed the assessments, except for a higher age.
COMPLIANCE 
75 of the 586 participants (12.7%) did not complete the two-year intervention (ParkFit n=44, con-
trols n=31). Main reasons were refusal to change from a regular physiotherapist to a ParkinsonNet 
physiotherapist, too much burden, or dissatisfaction with the intervention. Reasons for drop-out 
were similar between both groups. The mean number of annual individual visits to the physio-
therapist did not differ between ParkFit (13.6) and controls (13.0). Patients in both groups were 
satisfied with the intervention and would recommend the intervention to others (73% versus 71%).
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FIGURE 6.1
SCREENING, RANDOMIZATION, AND COMPLETION OF THE PRIMARY OUTCOME MEASURE
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No sedentary lifestyle* (n=1263) 
Severe disease** (n=464) 
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Did not speak Dutch (n=9) 
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 * No sedentary lifestyle = >3 times a week vigorous-intensity physical activity > 60 minutes; or >3 times a week 
moderate-intensity physical activity > 150 minutes; ** Severe disease = H&Y > III; MMSE < 24; severe co-morbi-
dity interfering with daily functioning; use of daily care in an institution; or deep brain stimulation
ParkFit
(n = 299)
Controls
(n = 287)
Demographics & Clinical Characteristics
Age 65.1 (7.9) 65.9 (7.2)
Men 194 (65%) 188 (65%)
BMI 27.4 (4.5) 27.6 (4.0)
Disease duration (years) 5.0 (4.5) 5.5 (4.6)
MMSE 28.1 (1.7) 28.1 (1.7)
Modiﬁ ed Hoehn and Yahr 
1 7 (2.3%) 4 (1.4%)
1.5 7 (2.3%) 10 (3.5%)
2 221 (73.9%) 223 (77.7%)
2.5 48 (16.1%) 36 (12.5%)
3 16 (5.4%) 14 (4.9%)
UPDRS III 33.1 (11.3) 32.3 (9.5)
Daily levodopa equivalent dose (mg) 458 (362) 499 (414)
Level of physical activity 
LAPAQ (hours per week) 12.8 (8.3 - 20.3) 13.8 (8.3 - 23.9)
Data refl ect mean (SD), median (IQ-range) or number (%). BMI = Body Mass Index (kg/m2). MMSE = mini-mental 
state examination. UPDRS III = unifi ed Parkinson’s disease rating scale part III. LAPAQ = LASA Physical Activity 
Questionnaire. 
TABLE 6.1
BASELINE CHARACTERISTICS
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LAPAQ N ParkFit N Controls Estimated 
difference (CI)*
p
Baseline 299 12.8 (8.3-20.3) 287 13.8 (8.3-23.9)
6 months 285 13.2 (9.2-20.5) 277 14.2 (8.5-22.0)
12 months 281 12.5 (7.2-21.1) 277 12.4 (7.3-17.9)
18 months 277 12.3 (7.0-19.0) 271 12.3 (6.8-19.1)
24 months 273 12.5 (6.3-18.4) 267 12.0 (7.0-18.3)
Estimated difference (CI)* 7% (-3% to 17%) 0.19
Data refl ect median (IQ-range); * estimated relative difference, based on mixed model analysis.
TABLE 6.2
EFFECT OF THE INTERVENTION (IN HOURS PER WEEK) ON THE LEVEL OF PHYSICAL ACTIVITY MEASURED 
WITH THE LASA PHYSICAL ACTIVITY QUESTIONNAIRE (LAPAQ)
ENDPOINTS
 Primary endpoint
 Compared to baseline, overall time spent in physical activities was comparable between both 
groups (adjusted group difference 7%; 95% confi dence interval (CI) -3 to 17%; p=0.19) (Table 6.2). 
 Secondary endpoints
 Both the activity diary and the activity monitor data suggested increased levels of physical acti-
vity in ParkFit patients (Table 6.3). Additionally, ParkFit patients increased their physical fi tness 
compared to controls (4.8 meters; 95% CI 0.1 to 9.6; p=0.05) (Table 6.3). Quality of life did 
not differ between the groups (-0.9 points; 95% CI -2.1 to 0.3; p=0.14).
 Safety and falls
 Eight patients died during follow-up because of cardiovascular problems, cancer or medical 
complications (ParkFit n=5, controls n=3). These deaths were unrelated to exercise sessions. 
Controls reported eight hip fractures, ParkFit patients two. Frequency and severity of all other 
adverse events were similar in both groups: ParkFit n=221, controls n=242. The number of 
patients with one or more falls was comparable in both groups: 184 (62%) in ParkFit and 191 
(67%) in controls.
N ParkFit N Controls Estimated 
difference (CI)*
p
Activity Diary
Baseline (hrs per week) 297 5.5 (3.1-10.3) 282 6.3 (3.3-10.5)
Median 6 to 24 months 276 7.6 (4.7-12.4) 276 6.9 (4.2-10.8)
Mean change 275 1.3 273 0.5 30% (17% to 45%) <0.001
Activity Monitor 
Baseline (kcal per day) 273 453 (368-618) 269 462 (346-604)
Median 6 to 24 months 269 504 (390-667) 269 440 (355-582)
Mean change 254 38.7 258 -14.2 12% (7% to 16%) <0.001
Quality of Life (PDQ-39)
Baseline 297 26.0 (13.7) 286 26.2 (13.1)
Mean 6 to 24 months 278 26.4 (13.7) 277 27.7 (12.7)
Mean change 278 0.1 276 1.7 -0.9 (-2.1 to 0.3) 0.14
Physical ﬁ tness (6MWT)
Baseline (distance in m) 298 391.6 (87.5) 283 392.9 (84.5)
Mean 12 and 24 months 256 404 (95.1) 256 394.4 (86.5)
Mean change 255 8.4 253 -1.6 4.8 (0.1 to 9.6) 0.05
Data refl ect mean (SD) or median (IQ-range); * estimated (relative) difference, based on analysis of covariance; PDQ-39 
= Parkinson’s Disease Questionnaire. 6MWT = 6-minute walk test.
DISCUSSION
 This RCT shows that a multifaceted behavioral change program does not promote overall phy-
sical activities in sedentary PD patients, as measured with the primary outcome (LAPAQ). Two of 
our secondary outcomes focused on other measures of physical activity, and did suggest impro-
vements for patients allocated to the ParkFit program. This was demonstrated both subjectively 
(with activity diaries) and objectively (with an ambulatory activity monitor). Moreover, physical 
fi tness (an indirect refl ection of greater physical activity) increased in ParkFit patients. Quality of 
life did not differ between both study arms. The ParkFit group did not experience more falls. 
TABLE 6.3
EFFECT OF THE INTERVENTION ON THE SECONDARY OUTCOME MEASURES
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 The ParkFit study is therefore a negative trial, showing no difference for the primary outcome 
(LAPAQ questionnaire) between both study arms. We selected the LAPAQ as primary outcome 
because it closely reflected the goals of the ParkFit intervention, namely promotion of physical 
activities. We regarded an actual increase in physical activity levels as a necessary intermediate 
and prerequisite to eventually obtain health benefits, including improvements in quality of life. The 
LAPAQ questionnaire is a validated instrument to measure habitual physical activity in large po-
pulations.55 156 LAPAQ covers a wide range of daily life activities, and we previously demonstrated 
that PD patients are 29% less active compared to controls, as measured with the LAPAQ.115 Our 
study was powered to defect a 20% increase based on the LAPAQ, which would equate to an 
increase in physical activities of two hours per week. The ParkFit program did not achieve this, 
suggesting that more robust interventions are needed to promote physical activities in daily life.
 Our choice for the control intervention might have obscured greater differences on the LAPAQ 
between ParkFit patients and controls. We chose to refer patients in the control arm to a physio-
therapist who aimed to improve the safety of movements, but without emphasizing the volume 
of physical activities. This approach helped to maintain blinding of patients with respect to 
treatment allocation. An additional reason for having a physiotherapy program as control in-
tervention was that abstaining control patients from physiotherapy for two years was considered 
unethical, in light of growing evidence for the effectiveness of specific physiotherapy interven-
tions.77 150-152 Furthermore, the ParkFit study took place in the ‘real world’, and physiotherapy 
in PD is ‘usual care’, not only in the Netherlands (where at least 60% of PD patients receives 
physiotherapy annually)7 but also in the United Kingdom.157
 Although no effect was found on the primary outcome, two of our secondary outcomes did pick 
up an increase in physical activities, as measured both subjectively (activity diary) and objectively 
(activity monitors). Based on the diary, ParkFit patients spent almost 1.5 hour per week extra on 
physical activity, compared to baseline. This differed significantly from controls, who increased 
their level of physical activity by 30 minutes compared to baseline. This amount of increase in 
physical activity, as observed with the diary, is comparable with findings in elderly populations 
and patients with other chronic conditions.158-161 For example, behavioral counseling for elderly 
in primary care yielded a one-hour increase in moderate-intensity physical activity.158 In addition, 
pedometer-based counseling programs increased total physical activity of cardiac patients by 
almost 1.5 hour/week.159 160 Both the LAPAQ and the diary are subjective instruments, but only the 
diary showed increased activity levels. One possible explanation for this discrepancy is the fact 
that the diary merely includes strenuous activities, while the LAPAQ questionnaire reflects the net 
sum of all physical activities (including household activities). Therefore, we cannot exclude that 
a possible increase in (strenuous) outdoor and sport activities for ParkFit patients was offset by a 
concurrent decrease in household activities. The LAPAQ cannot capture such differential effects 
on specific physical activities as it merely measures the net sum of all physical activities. We there-
fore regard our decision to select overall physical activity as primary outcome as a shortcoming 
in the study design, and this aspect should be addressed in future research in this area.
 Objective assessment of physical activity using a tri-axial accelerometer showed an increase in 
physical activities for ParkFit patients, with a 12% increase in time spent to physical activity after 24 
months. Generally, accelerometers underestimate total energy expenditure, because some activi-
ties are difficult to detect. This includes upper body movements, specific activities such as cycling, 
and relatively static movements such as gardening or strength training.68 On the other hand, ac-
celerometers as used in our study can reliably measure activities such as indoor and outdoor wal-
king.88 128 The accelerometers thus measured a different aspect of physical activity as compared 
to the LAPAQ, and this could explain the difference in outcome with the LAPAQ. Compliance with 
use of the accelerometers was good, suggesting it is a feasible surrogate outcome in future studies. 
The two remaining secondary outcomes aimed at finding possible health benefits. Physical fit-
ness showed a small but significant difference in favor of ParkFit, but quality of life did not differ 
between the ParkFit and control intervention. The ParkFit intervention had no major adverse 
effects. We were concerned about possibly increased fall rates, because the amount of physical 
activity is associated with a greater risk of falling.162 However, the ParkFit program was not as-
sociated with more falls or injuries. In fact, controls reported eight hip fractures, while ParkFit 
patients reported only two. However, these numbers are very small, and this finding is coinci-
dental as we did not include hip fractures as primary or secondary outcome. Therefore, further 
research should investigate whether this difference in hip fractures is related to the intervention. 
Another concern included cardiovascular complications, due to more strenuous activities. All 
participants received a sports health assessment prior to participation. We observed two cardio-
vascular deaths in the ParkFit group, but these were unrelated to exercise. Other adverse effects 
were comparable between both groups. Taken together, this suggest that ParkFit was a safe 
intervention, but that the program needs to be adjusted to achieve more substantial increases in 
physical activity that translate into tangible health improvements.
 Our experience with this ParkFit study was a lesson in trial design in this newly emerging field. 
Although the primary outcome was negative, we have shown the possibility of an exercise based 
trial in disabled people. Several features set the ParkFit study apart compared to previous exercise 
studies: the prolonged follow-up, showing that patients in both arms were able to comply with the 
intervention for two years; the careful matching of treatment intensity between both study arms; 
the large sample size, making the ParkFit trial by far the largest study on physical activity in PD and 
other chronic diseases;19 77 159 160 and the excellent follow-up rate. The feasibility of the study was 
supported by the ParkinsonNet infrastructure, a nationwide network of allied health professionals 
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who are specialized in PD.12 A generic challenge for trials aiming to evaluate the merits of allied 
health treatment is the lack of expertise among therapists who deliver the trial intervention, crea-
ting undesirable variability and insufficient contrast with the control arm. Having expert therapists 
within ParkinsonNet greatly facilitates the delivery of a relatively uniform intervention according to 
treatment guidelines.13 163 As discussed above, our study also highlights the challenges of selecting 
the appropriate outcomes for a complex intervention such as a behavioral change program. 
Physical activity is a complex behavior: it includes sports as well as non-sports activities, and it can 
be characterized by purpose (occupational or leisure), type (cycling, fitness or soccer), intensity 
(light, moderate or vigorous) and duration. Further research should focus on comprehensive, va-
lid and reliable instruments to accurately measure all these aspects of physical activity behavior. 
This is a specific challenge in patients with chronic diseases as they perform more light and mo-
derate activities that are easily overestimated when using questionnaires, and which are difficult 
to detect with activity monitors. Furthermore, our trial revealed new insights in the risk of selection 
bias. Our participants were on average less sedentary compared with patients who declined to 
participate.42 Hence, those who needed to promote their physical activities most refused partici-
pation. It therefore remains unclear whether the effects found here can be generalized to more 
sedentary PD patients. We can neither extend our findings to patients with severe apathy, severe 
cognitive impairment or depression, because these were excluded. Finally, the ParkFit program 
was a multifaceted intervention, with coaches using behavioral change techniques, ambulatory 
feedback devices, and peer pressure from group exercises. Future work should decide which of 
these components is most effective, and if any component is also effective when used alone.
 We conclude that ParkFit, a multifaceted behavioral change program, does not change the 
overall volume of physical activities in older, sedentary PD patients. However, analysis of the 
secondary outcomes did suggest greater participation in specific elements of physical activity, 
and demonstrated an improved fitness among ParkFit patients. These results for the secondary 
outcomes suggest that it may be worthwhile to replicate a similar behavioral change study, for 
example with the secondary outcomes as primary parameters. Such a trial may also put more 
focus on quality of life and cost aspects.
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ABSTRACT
BACKGROUND
 We recently completed the ParkFit study, a two-year randomized controlled trial including 586 
sedentary PD patients, that evaluated a multifaceted intervention (ParkFit program) to promote 
physical activity. Analysis of the secondary outcomes suggested greater participation in specif-
ic elements of physical activity, and demonstrated an improved fitness among ParkFit patients.
Therefore, further implementation of the program could now be considered. To facilitate this pro-
cess, we here evaluate the implementation of the ParkFit program.
METHODS 
 The ParkFit program was evaluated in three ways: (a) experiences of patients and physiotherapists, 
as investigated using interviews and questionnaires; (b) factors associated with changed activity 
levels; and (c) subgroup analyses to identify differential effects in subgroups of patients based on 
baseline physical activity level, age, gender, disease severity, disease duration, and mobility.
RESULTS
 The ParkFit program was well received: 73% of patients indicated they would recommend the 
program to other patients, and 90% of physiotherapists indicated they wanted to use the ParkFit 
program in other patients. The program was effective in almost all subgroups. In women, most 
sedentary patients and patients with lower disease severity, the estimated effect size was largest.
CONCLUSION
 We conclude that the ParkFit program was effective in almost all specific subgroups. Therapists 
and patients experienced no major hurdles. This knowledge can be used for further implementati-
on into everyday clinical practice to revert the sedentary behavior of patients with PD, and perhaps 
other chronic conditions as well.
INTRODUCTION
Patients with PD are less active compared 
with controls, and this physical activity wors-
ens with disease progression.115 Reversing 
sedentary lifestyles could have various ge-
neric benefits, including increased survival17 
18 and lower risks of chronic diseases as car-
diovascular disease, diabetes, and cancer.14 
Promoting physical activity may also improve 
specific symptoms of PD, such as insomnia, 
depression, and constipation.19 Moreover, ro-
dent work suggests that physical activity may 
counter neurodegeneration in experimental 
parkinsonism.76 84 This observation has fueled 
speculation that physical activity might be 
used to alter the course of PD in humans.
Many patients are well aware of these po-
tential benefits, but changing a sedentary 
lifestyle is difficult. Simply knowing about the 
importance of physical activity is not enough 
to initiate and maintain an adequate physical 
activity level on a regular basis, and it proves 
tremendously difficult to give up unhealthy 
behavior.164 Changing one’s lifestyle when 
old or suffering from a chronic disease such 
as PD is even harder due to physical limita-
tions (e.g. gait and balance impairment) and 
mental changes (e.g. depression, apathy and 
cognitive impairment). 
Considerable research has aimed to develop 
tools for clinicians to enable such high-risk 
groups to successfully change their lifestyle. 
Several physical activity promotion programs 
have shown to be effective; these programs 
were based on healthy behavior theories, 
used behavioral change strategies and were 
individually tailored.164 165 Such a specific 
intervention program that considered the 
complexity of PD and that addressed all pos-
sible barriers was not available until recently. 
Therefore, we developed the ParkFit pro-
gram, an individually tailored and disease-
specific program for patients with PD. In a 
multicentre, randomized controlled trial in-
cluding 586 sedentary PD patients, the Park-
Fit program was compared with a matched 
physiotherapy intervention according to the 
evidence based guideline.11 
The ParkFit program was solely delivered by 
experienced physiotherapists who participate 
in the Dutch ParkinsonNet.13 In total, 116 
physiotherapists offered the ParkFit program 
to 299 patients. 
Although the primary analysis of the ParkFit 
trial showed no differences in levels of activity, 
our secondary outcomes showed increased 
physical activity and improved fitness, with-
out causing more falls (van Nimwegen M 
and Speelman AD et al., BMJ 2012, in press). 
Stimulated by these findings, further imple-
mentation of the ParkFit program into clinical 
practice could now be considered. To facili-
tate this potential implementation process, we 
here evaluate the implementation of the Park-
Fit program. Specifically, our analyses focused 
on: (a) experiences of therapists and patients 
with the ParkFit program; (b) factors associ-
ated with changed activity levels; and (c) sub-
group analyses, to identify whether specific 
subgroups of patients might benefit less or 
more from the ParkFit program.
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METHODS
THE PARKFIT STUDY
 This study was part of the ParkFit study, a randomized controlled multi-centre trial aiming to in-
crease physical activity levels over a course of two years in sedentary PD patients (van Nimwegen 
M and Speelman AD et al., BMJ, 2012 - in press). Patient characteristics were presented in Table 7.1. 
Ethical approval has been granted for the study and all patients signed informed consent. The 
full study protocol has been described elsewhere.42 
PARKFIT PROGRAM
 The ParkFit program was specifi cally designed to achieve a sustained increase in the level of 
physical activity and was based both on theories and models of behavioral change33 34 and on 
behavioral change techniques with proven effectiveness.35 38 41 
 Activity Coach
 Physiotherapists served as personal activity coaches who guided patients towards a more active 
lifestyle during monthly personal coaching sessions. Physiotherapists educated patients about 
the benefi cial effects of physical activity and about suitable activities. Additionally, patients were 
stimulated to participate in group exercise to experience benefi cial effects of physical activity 
and to receive social support from fellow patients. 
 Education & Health contract
 Patients received an educational workbook covering specifi c elements to promote a behavioral 
change. This brochure gave information about the benefi ts of physical activity and the risks of 
a sedentary lifestyle. Furthermore, suitable activities for PD patients, strategies to identify and 
overcome barriers to engage in physical activity, setting goals and recruiting social support were 
covered. The workbook included a health contract, a written agreement between patient and 
physiotherapist to support patients in initiating and maintaining physical activities by formulating 
long term activity goals.41 Additionally, a logbook was included to monitor short term goals. 
Patients received a bi-annual newsletter accentuating the benefi ts of physical activity.
 Goal setting
 During the coaching sessions patients and physiotherapists formulated activity goals. These 
goals were created in order to obtain the long term goals as formulated in the health contract. 
During the coaching sessions patient and therapists evaluated these goals as well as the expe-
rienced barriers. The formulated activity goals had to be realistic, concrete and individualized 
and had to be formulated in a systematic way. 
 Activity Monitor
 All patients received a personal ambulatory monitor.88 This triaxial accelerometer was able to 
show the amount of actually delivered daily physical activity using light-emitting diodes. At a 
personalized website, patient and coach could formulate a personal goal based on kilocalories; 
feedback of the monitor was directly related to this personal goal. Since data of the monitor 
were uploaded to this website, patient and coach could monitor the individual progress.166
 Physiotherapy
 The ParkFit program also included regular physiotherapy sessions. Based on individual disabili-
ties, the therapist and patient jointly formulated individually tailored treatment aims, according 
to the evidence-based guideline of physiotherapy for PD.11
ParkFit
(n = 299)
Controls
(n = 287)
Demographics & Clinical Characteristics
Age 65.1 (7.9) 65.9 (7.2)
Men 194 (65%) 188 (65%)
BMI 27.4 (4.5) 27.6 (4.0)
Disease duration (years) 5.0 (4.5) 5.5 (4.6)
MMSE 28.1 (1.7) 28.1 (1.7)
Modiﬁ ed Hoehn and Yahr 
1 7 (2.3%) 4 (1.4%)
1.5 7 (2.3%) 10 (3.5%)
2 221 (73.9%) 223 (77.7%)
2.5 48 (16.1%) 36 (12.5%)
3 16 (5.4%) 14 (4.9%)
UPDRS III 33.1 (11.3) 32.3 (9.5)
Daily levodopa equivalent dose (mg) 458 (362) 499 (414)
Level of physical activity
LAPAQ total 12.8 ( 8.3 - 20.3) 13.8 (8.3 - 23.9)
LAPAQ outdoor and sport activities 5.7 ( 3.0 - 10.3) 6.0 (3.5 - 10.3)
LAPAQ household activities 5.0 (2.0-10.7) 5.3 (2.0-13.0)
Data refl ect mean (SD), median (IQ-range) or number (%). BMI = Body Mass Index (kg/m2). MMSE = mini-mental state 
examination. UPDRS III = Unifi ed Parkinson’s disease Rating Scale, part III. LAPAQ = LASA Physical Activity Questionnaire.
TABLE 7.1
BASELINE CHARACTERISTICS
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IMPLEMENTATION OF THE PARKFIT PROGRAM 
 We took several steps to enable a successful implementation of the ParkFit program. We first de-
veloped a specific handbook for physiotherapists, including: (a) information about the benefits and 
risks of physical activity; (b) information about the process of behavioral change; (c) specific user-
information for the tools included in the ParkFit program (health contract, activity monitor); and (d) 
a scheme including each coaching session, to help therapists through the coaching sessions. 
 Second, we developed the educational workbook for patients which included all elements of 
the ParkFit program. This workbook was not only intended to inform patients, but also to guide 
therapists in dealing with all specific elements important for behavioral change. Third, physio-
therapists were trained to treat patients in the ParkFit program during three educational sessi-
ons. These sessions covered the following items: (a) models and theories of behavioral change; 
(b) general strategies to coach people and to help them to overcome barriers; (c) techniques 
to formulate realistic, concrete and individualized goals; and (d) how to cope with differences 
in character between patient and therapist, because this greatly influences behavior. The spe-
cific elements included in the ParkFit program were also explained, such as use of the Activity 
Monitor, the educational workbook, the logbook and the health contract. 
 During the two-year intervention period, therapists could consult the research team at any time 
for advice. Moreover, the research team contacted therapists every three months by telephone 
to investigate whether they experienced barriers in delivering the ParkFit program. Finally, after 
one year, an evaluation meeting with therapists was scheduled. These meetings aimed to refresh 
the knowledge of the various ParkFit elements and to discuss therapists’ experiences. 
EVALUATION OF THE PARKFIT PROGRAM
 Experiences 
 Therapists were interviewed by four independent researchers three to six months after the start 
of the intervention. This telephone interview included various aspects related to the ParkFit pro-
gram. Immediately after ending their participation in the trial, therapists and patients were asked 
to complete a self-administered questionnaire with questions regarding patients’ and therapists’ 
opinions about the program. 
 Factors associated with changed activity levels
 In the ParkFit study, the level of physical activity was primary measured with the LASA Physical 
Activity Questionnaire (LAPAQ).55The LAPAQ questionnaire reflects the net sum of ‘outdoor and 
sport activities’ plus ‘household activities’. Post hoc analyses of the ParkFit trail showed that a sig-
nificant and possibly relevant increase (24%) in outdoor and sport activities for ParkFit patients was 
offset by a concurrent decrease in household activities. Here, we indentified variables that could 
be associated with this change in ‘outdoor physical activity’ as measured with the LAPAQ.
 The following variables were evaluated: disease severity (Unified Parkinson’s Disease Rating 
Scale motor part (UPDRS III), Hoehn and Yahr stage (HY)) 167, disease duration (years), quality of 
life (Parkinson’s Disease Questionnaire (PDQ-39))153, mobility (Timed Up and Go test (TUG)),61 
bradykinesia (Nine hole pegboard test, (NHPT)), fatigue (Fatigue Severity Scale (FSS)),99 anxiety 
and depression (Hospitality Anxiety and Depression Scale (HADS))60, physical fitness (6-minute 
walk test (6MWT))95, and levodopa equivalent dose (mg). Moreover, general characteristics as 
body mass index (BMI), gender, age, and marital status were assessed. 
 Subgroup analyses
 In an exploratory setting, the effectiveness of the ParkFit program was evaluated in specific sub-
groups. Subgroups were defined based on baseline physical activity level, age, gender, disease 
severity (UPDRS III), disease duration, and mobility (TUG). For each variable we classified two 
subgroups based on the median of the whole group. 
STATISTICAL ANALYSES
 Descriptive statistics were used to present quantitative data (i.e. means and percentages). 
Univariate linear regression analyses were performed to study associations between the chan-
ge in level of physical activity during the entire follow-up period (i.e. mean of 6, 12, 18 and 24 
months) and the possible variables (assessed at baseline). Variables that contributed signifi-
cantly were included in a forward multivariate linear regression analysis. Because the physical 
activity level was skewed, medians and interquartile ranges were presented, and analyses 
were performed after logarithmic transformation. Furthermore, linear regression analyses 
were performed to determine differences in subgroups for changes in level of physical activity, 
changes in quality of life (i.e mean of 6, 12, 18 and 24 months) and changes in physical fitness 
(i.e. mean of 12 and 24 months) between both interventions. Fixed factors were treatment 
arm, score at baseline (level of physical activity, quality of life or physical fitness), H&Y stage, 
age and gender.
RESULTS
EXPERIENCES
 Physiotherapists
 Out of 116 therapists, 113 (97%) were interviewed. The mean number of patients treated by 
each therapist was 2.4 (range 1 – 13). Therapists identified patients’ physical limitations (63%), 
uncertainty about their abilities and fear of falling (41%), and declined cognition (41%) as the 
most important explanations for their lifestyle. Nearly all therapists (96%) felt competent to offer 
the specific ParkFit intervention. Only 1% of therapists believed that their knowledge of behavi-
oral change was not sufficient. Seventy-eight percent was able to deliver the program always or 
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Univariate regression
(95% CIs)
Multivariate regression 
(95% CIs)
Level of physical activity
LAPAQ outdoor and sport activities -43.8 (-47.3, -40.1)* -44.8 (-48.3, -41.3)
Demographic characteristics
Age -1.6 (-2.7, -0.5)*
Gender (men = 0) -12.7 (-26.7, 3.8)
Partner (no partner = 0) 5.1 (-16.2, 31.9)
BMI 0.0 (-2, 1.9)
Disease characteristics
Modiﬁ ed Hoehn and Yahr -12.5 (-32.4, 13.3)
UPDRS III -0.6 (-1.4, 0.2)
Disease duration (y) 2.0 (0.2, 3.9)*
Daily levodopa equivalent dose (mg) 0.0 (0, 0)
Additional clinical characteristics
6MWT 0.1 (0, 0.2)
TUG -2.5 (-4.9, -0.1)* -4.7 (-6.5, -2.8)
PDQ-39 0.1 (-0.5, 0.7)
NHPT 0.3 (-0.5, 1.1)
FSS -1.1 (-6.3, 4.3)
HADS 0.2 (-1.1, 1.5)
SCOPA night 0.8 (-1.6, 3.3)
SCOPA day 0.4 (-2.1, 2.8)
  LAPAQ = LASA Physical Activity Questionnaire. BMI = Body Mass Index (kg/m2). UPDRS III = unifi ed Parkinson’s 
disease rating scale part III. 6MWT = 6-minute walk test. TUG = Timed up and Go test. PDQ-39 = Parkinson’s 
Disease Questionnaire. NHPT = nine hole peg board test. FSS = Fatigue Severity Scale. HADS = Hospital Anxiety 
and Depression Scale.
TABLE 7.3
REGRESSION COEFFICIENTS (%) AND 95% CONFIDENCE INTERVALS FOR UNIVARIATE AND MULTIVARIATE 
ANALYSES BETWEEN THE CHANGE IN PHYSICAL ACTIVITY (LAPAQ OUTDOOR AND SPORT ACTIVITIES) 
AND THE EXPLORATORY FACTORS MEASURED AT BASELINE
very often. Main reasons for not succeeding were: patients' co-morbidity, cognitive disturbances, 
patients’ lack of motivation, and increased disease severity. Formulating concrete and smart 
activity goals was diffi cult according to the therapists; patients’ physical limitations and cognitive 
decline were the main reasons for diffi culties in goal setting. Almost all therapists (96%) conside-
red that their patients were motivated to participate in the ParkFit program. Ninety-three percent 
completed the questionnaire at the end of the study. Therapists reported education (94%) and 
the coaching sessions (93%) as the main tools of the ParkFit program (Table 7.2). Most therapists 
(91%) said they would apply the ParkFit program in other patients with a sedentary lifestyle; 89% 
would offer the program to other PD patients. Twenty-one therapists (15%) mentioned suggesti-
ons to improve the program.
 Patients
 Out of 299 patients, 255 (85%) completed the questionnaire. Almost all patients (90%) re-
ported they perceived benefi ts due to the intervention. Seventy-three percent would certainly 
recommend the program to other patients with PD, and 21% would consider recommending the 
program. The most popular tool for patients was the Activity Monitor; 83% of patients identifi ed 
this device as a (very) useful instrument (Table 7.2).
FACTORS ASSOCIATED WITH CHANGED ACTIVITY LEVELS
 Lower age, longer disease duration, better mobility, and lower baseline levels of physical activity 
were associated with larger changes in physical activity (Table 7.3). Multiple forward regression 
analysis resulted in a model with two variables: less baseline physical activity, and better mobility 
were associated with larger changes in levels of physical activity (R2=38%) (Table 7.3). 
TABLE 7.2
PERCENTAGES OF BOTH PATIENTS AND THERAPISTS WHO  CLASSIFIED THE ELEMENTS OF THE PARKFIT 
PROGRAM AS USEFUL
Patients
(n=250)
Physiotherapists
(n=108)
Education 77% 94%
Goal setting (short term) 60% 88%
Goal setting (long term) 59% 83%
Coaching sessions 71% 93%
Activity Monitor 83% 75%
Sport sessions 58% 74%
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Change in
Physical activity
Change in 
Quality of Life
Change in 
Physical Fitness
All patients 24% (10% to 40%)* -0.9 (-2.1 to 0.3) 4.8 (0.1 to 9.6)*
Subgroups of patients
Age#
< 67 17% (-1% to 38%) -1.0 (-2.6 to 0.6) 6.1 (-7.3 to 19.5)
> 67 38% (13% to 68%)* -0.8 (-2.6 to 1.0) 17.0 (2.6 to 31.4)*
Gender##
Men 19% (3% to 37%)* -0.8 (-2.2 to 0.6) 9.1 (-2.8 to 20.9)
Women 40% (10% to 80%)* -0.6 (-2.7 to 1.6) 12.0 (-4.4 to 28.4)
Disease duration (years)
< 3.75 27% (5% to 54%)* -1.4 (-3.0 to 0.3) 15.9 (2.7 to 29.0)*
> 3.75 23% (3% to 47%)* 0.13 (-1.6 to 1.9) 4.6 (-9.5 to 18.7)
Disease severity (UPDRS III)
< 32 24% (3% to 51%)* -1.7 (-3.4 to -0.05)* 15.0 (1.7 to 28.4)*
> 32 30% (9% to 55%)* -0.2 (-1.9 to 1.6) 7.4 (-6.5 to 21.3)
Mobility (TUG, seconds)
< 9.25 28% (7% to 52%)* -1.2 (-2.8 to 0.4) 10.5 (-0.8 to 21.9)
> 9.25 21% (-0.1% to 46%) -0.3 (-2.2 to 1.5) 9.3 (-6.0 to 24.6)
Baseline physical activity (hours)
< 6 34% (10% to 64%)* -0.2 (-2 to 1.6) 1.0 (-13.5 to 15.5)
> 6 17% (-0.1% to 38%) -1.3 (-2.9 to 0.3) 18.3 (5.5 to 31.0)*
Data refl ect estimated differences and 95% confi dence intervals; analyses were corrected for age, gender, H&Y, 
and baseline level; #without correction for age; ##without correction for gender; *p < 0.05. Physical activity was 
measured with the LASA Physical Activity Questionnaire (LAPAQ); quality of life was measured with the Parkinson’s 
Disease Questionnaire (PDQ-39); physical fi tness was measured with the 6-minute walk test (6MWT). UPDRS III = 
motor part of the Unifi ed Parkinson’s Disease Rating Scale; TUG = Timed up and Go test. 
TABLE 7.4
EFFECT SIZES OF THE PRIMARY AND SECONDARY OUTCOME MEASURES IN ALL PATIENTS AND 
FOR SUBGROUPS OF PATIENTS BETWEEN PARKFIT AND CONTROLS
SUBGROUP ANALYSES
 The ParkFit program was effective in changing the level of physical activity in almost all sub-
groups, except for patients younger than 67, patients with lower mobility scores and more phy-
sically active patients at baseline (Table 7.4). The estimated difference between ParkFit and 
controls was largest in the most sedentary patients (estimated group difference 34%, 95% 
Confi dence Interval (CI) 10 to 64%), women (40%, CI=10 to 80%), and patients older than 67 
(38%, CI=13 to 68%) (Table 7.4). The ParkFit program was effective in changing physical fi tness 
in different subgroups (Table 7.4). Quality of life changed only in patients with lower disease 
severity (-1.7, CI=-3.4 to -0.05%) (Table 7.4).
DISCUSSION
 We aimed to evaluate the trial experience with the ParkFit program, as a basis to facilitate fu-
ture implementation into clinical practice. Both therapists and patients were positive about the 
intervention. Almost all therapists wished to use the ParkFit program in other patients, and 73% 
of patients would recommended the program to other patients. Subgroup analyses revealed 
that the program was effective in almost all subgroups. The most sedentary patients, women, 
patients with lower disease severity, shorter disease duration and elderly patients appeared to 
benefi t relatively most.
 The different elements of the ParkFit program were offered as a ‘total package’ to achieve a 
behavioral change. Since therapists were educated to offer this multifaceted program and we 
evaluated the program likewise, we cannot conclude whether specifi c elements were more or 
less effective. However, the results of the questionnaire gave some insight in the perceived suc-
cess of the various components. Specifi cally, therapists reported education and the coaching 
sessions as main tools of the ParkFit program, while most patients reported the Activity Monitor 
as the most useful tool. Clearly, these three elements deserve optimal attention when delivering 
the ParkFit program in clinical practice. Future work is needed to decide which component is 
most effective in increasing physical activity levels, and if any component of the ParkFit program 
will also be effective when used in isolation. 
 The program had an excellent compliance: 85% of patients in the ParkFit program completed the 
total intervention (van Nimwegen M and Speelman AD et. al, BMJ 2012, in press). Our results 
concerning adherence are comparable with previous short-term programs (up to 6 months)168 
169 but remarkably higher compared with previous long-term programs (up to 14 months).170 In 
an exercise program of six months aiming to reduce fall risk in PD, 54% of patients completed 
at least 75% of the sessions.169 Another study of group exercise in PD found an attendance rate 
of 73% during 14 months.170 Several aspects of our program could have contributed to its high 
promotion of physical activity in parkinson's disease • the challenge to change behavior
100 101
evaluation of implementation of the parkfit program 0707
adherence. First, the individually tailored character of the intervention – with activities that par-
ticipants enjoyed – makes participation more palatable compared with exercise in general.165 
Since patient and therapist jointly chose one or more (sport) activities, patients were allowed 
to follow their own wishes, adjusted to the individual situation. Second, the disease-specific 
knowledge of the therapists could explain the high adherence. The intervention was delivered 
solely by experienced physiotherapists participating in the Dutch ParkinsonNet.13 ParkinsonNet 
networks were specifically developed to improve the PD-specific expertise of health professio-
nals, and to increase patient volumes per therapists.13 Probably, due to these specific elements, 
therapists were able to adequately anticipate on perceived barriers of PD patients, and this 
could have improved patients’ adherence. Most patients who withdrew from the intervention 
did so just after baseline inclusion (4.7%). After about six months, another 5% of patients had 
stopped with the program. Apparently, once patients participate and perceive no ‘starting’ pro-
blems, there are hardly no reasons to stop with the intervention. This suggests that the program 
is feasible and achievable for patients. Besides the excellent compliance of patients, almost all 
involved therapists delivered the intervention for two years and completed both the interview and 
the questionnaire. This shows great enthusiasm and interest with the ParkFit program.
 Multivariate regression showed that larger changes in levels of physical activity were associated 
with less baseline physical activity. The major part of the explained variance was explained by 
baseline physical activity. This could be a simple regression to the mean effect, but it could also 
suggest that poor daily participation in exercise is no reason to withhold patients a physical 
activity program such as ParkFit. Furthermore, better mobility was associated with greater in-
creases in physical activity after two years. Moreover, therapists reported that patients without 
comorbidities and cognitive disturbances were more easy to stimulate towards an active lifestyle. 
Therefore, physiotherapists should take poor baseline mobility, physical limitations, baseline 
physical activity levels, and cognitive functioning of patients into account before starting a be-
havioral change program, for example by engaging the immediate caregiver into the program. 
Perhaps, patients should receive treatment (e.g. by increasing dopaminergic medication, or by 
offering physiotherapy strategies such as cueing) prior to participation.
 Subgroup analyses showed significant differences for almost all subgroups between patients in 
the ParkFit program and controls. In the subgroups of women, patients with lower disease seve-
rity and patients with a shorter disease duration, the benefits from the ParkFit program seem to 
greater. However, these results should be interpreted with caution, because the study was not 
set up to compare subgroups and had insufficient power to reliably detect differences. As such, 
the present results serve only as hypothesis-generating, which call for further confirmation in 
new studies. This work could focus on some promising hypotheses that came from our current 
research, suggesting that specific subgroups may benefit more than others. Specifically, further 
research should focus on the effects of ParkFit-like interventions in women, patients with lower 
disease severity and patients with a shorter disease duration.
 The ParkFit program was now offered solely by physiotherapists with PD-specific expertise, which 
likely helped to overcome any barriers imposed by the physical limitations. The question is 
whether adding professionals from other disciplines might help to improve the quality of the 
behavioral change program. One example that came from the interviews was a psychologist, 
who could address the cognitive issues associated with PD, but who also adds specific expertise 
to change behavior. One could also consider adding sport instructors, since they have specific 
knowledge about coaching, counseling, sports and exercise. It will be interesting to examine the 
possible role of such sport instructors within the ParkFit program. For example, we anticipate 
that patients with greater disease severity will require more specific knowledge of a specialized 
physiotherapist, while patients in earlier stages could be coached solely by a sport instructor.
CONCLUSION
 Our analysis of the ParkFit program yielded several suggestions for improvement: 1) improve edu-
cation for therapists with respect to theories about behavioral change; 2) formulate concrete and 
specific examples of exercise goals; and 3) pay more specific attention to patients with co morbidi-
ties, cognitive dysfunction and a lack of motivation during education. Sedentary behavior is a major 
public health problem, and physical activity can have various specific benefits for patients with PD. 
We therefore recommend further implementation of this program into everyday clinical practice. 
ACKNOWLEDGEMENTS
 We thank all patients and physiotherapists for participation. We would like to thank I. Boers, D. 
Drijkoningen, G. Kastenberg-van Spijker, and J. Tra for their contribution during data collection. 
Furthermore, we would like to thank T. Roordink, M. Gerrits and W. Trompers for their contribution.
 
 This study was primarily funded by ZonMw (The Netherlands Organization for Health Research 
and Development (75020012)) and The Michael J Fox Foundation for Parkinson’s research. 
Additional financial support was provided by VGZ (health insurance company); Glaxo Smith 
Kline; and National Parkinson Foundation.
08SUMMARYCHAPTER
promotion of physical activity in parkinson's disease • the challenge to change behavior
104 105
summary 0808
CHAPTER 2 
PHYSICAL INACTIVITY IN PARKINSON’S DISEASE
 Patients with Parkinson’s disease are widely presumed to follow a sedentary lifestyle, due to their 
physical, cognitive and emotional impairments. Nevertheless, only a few studies have thus far 
examined physical activity in PD, and the results were inconsistent. In Chapter 2, we provided 
new evidence to demonstrate the presence of physical inactivity in PD. Daily physical activity 
levels of patients with PD were compared with controls; data were obtained using a validated 
physical activity questionnaire (LASA Physical Activity Questionnaire (LAPAQ)). 
 The results showed that patients were physically less active; a reduction of 29% in daily physical 
activities was found (95% CI, 10% to 44%). The loss of time spent on activities was most obvious 
in patients with greater disease severity. We also investigated the infl uence of disease-related 
factors on daily physical activities in patients with PD. M ultivariate regression analyses demon-
strated that greater disease severity, gait impairment, and greater disability in daily living were 
associated with daily physical activities in PD (R2=24%).  
CHAPTER 3
DESIGN AND INTERVENTION OF A RANDOMIZED 
CONTROLLED TRIAL TO PROMOTE PHYSICAL ACTIVITY 
IN PATIENTS WITH PARKINSON’S DISEASE
 Participating in regular physical activity reduces the risk of chronic diseases such as cardio-
vascular diseases, type 2 diabetes mellitus, osteoporosis and obesity. Moreover, promotion 
of physical activities may benefi cially affect the clinical presentation of PD, and perhaps even 
modify the course of PD. However, changing a sedentary lifestyle is diffi cult; to increase physical 
activity in old persons or in patients with a chronic disease may be even harder. We developed 
a multifaceted intervention to promote physical activity in sedentary patients with PD (the ParkFit 
program). We designed a multicentre, randomized controlled trial comparing the ParkFit pro-
gram with a matched general physiotherapy intervention. 
 The ParkFit intervention program was based on theories and models of behavioral change and 
on widely used behavioral change techniques with proven effectiveness. Important elements of 
the program were: (a) the physiotherapist as activity coach who guided each individual patient 
towards a more active lifestyle during monthly personal coaching sessions; (b) a brochure with 
 Patients with PD are less active compared with controls. This reduction is in part related to gre-
ater disease severity, more severe gait impairment, and greater disabilities in daily living. 
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education about the benefi ts of physical activity and suitable activities for PD patients; (c) iden-
tifying and overcoming any perceived barriers to engage in physical activity; (d) systematic goal 
setting, using a health contract and logbook; (e) stimulating patients to participate in group 
exercises to experience social support from peers; and (f) an ambulatory monitor with automa-
ted feedback. Chapter 3 described the ParkFit program and the design of this large randomized 
controlled trial. The primary outcome of the trial was the change in physical activity over the 
course of two years measured with the LAPAQ, an interview-based 7-day recall. The trial would 
also search for possible health benefi ts and risks of increased physical activity in PD. 
CHAPTER 4
MULTIVARIABLE ANALYSES OFTEN HAVE MULTIPLE 
SOLUTIONS; AN EXAMPLE
 When we used forward variable selection to identify factors that were related to the level of phy-
sical activity in Parkinson’s disease patients (Chapter 2), we found a model with four variables. 
This model explained 22% of the variance in physical activity. Although this R2 value indicated 
a poor fi t, additional variables were unlikely to contribute to a better fi t; the model with all va-
riables explained only 24% of the variance. In Chapter 4, we showed that several other models 
seemed equally appropriate to describe the relationship between the independent factors and 
the physical activity level. As a consequence, it was impossible to determine one ‘best’ combi-
nation of independent factors explaining physical activity in patients with PD. 
 The ParkFit trial evaluates a new, multifaceted intervention program to achieve an enduring 
increase in physical activity specifi cally in patients with PD. The intervention is based on motiva-
tional and behavioral change models, which are employed for the fi rst time in patients with PD.
 Several models seem appropriate to describe the relationship between ‘personal and disease 
related factors’ and physical activity levels in PD patients. When the purpose of a multivariable 
analysis is to identify which combination of independent factors explains a certain outcome, the 
‘best-fi tting’ model, as well as all other models with a comparable percentage declared vari-
ance, should be reported.
CHAPTER 5 
QUANTIFYING LEVELS OF INACTIVITY IN 
PARKINSON’S DISEASE PATIENTS AND ITS DETERMINANTS
 Questionnaires are widely used to measure daily physical activity in large populations. However, 
due to their subjective character, they might result in an under- or overestimation of the per-
formed physical activities. The ParkFit study intended to include sedentary patients, based on a 
physical activity screening questionnaire. It was not clear whether these self-reported sedentary 
patients also had objective evidence for a sedentary lifestyle, as determined using quantitative 
accelerometry measurements. The aim of this study was to objectively assess physical activity 
behavior of all sedentary participants of the ParkFit study. Physical activity behavior was measu-
red over seven days using a linear triaxial accelerometer which was worn as a necklace, on the 
belt or in the pocket. Determinants of daily physical activity were additionally identifi ed. 
 In total, 467 patients (80%) had valid accelerometry measurements on at least seven consecutive 
days.133 Median total energy expenditure was 464 kilocalories per day and participants spent 12 
minutes per day on moderate or vigorous intensive activities. Consequently, none (except for one) of 
the participants met the recommendations for healthy physical activity (i.e. moderate-intensity cardio 
respiratory exercise training for at least 30 minutes per day for at least fi ve days a week, which should 
take place in bouts of at least 10 minutes).15 Higher age, female gender, less physical fi tness and 
greater motor problems were related to less daily physical activity (R2=0.69; p<0.001).
 
CHAPTER 6 
RESULTS OF THE PARKFIT STUDY
 he results of the ParkFit study showed that overall time spent in physical activities was compara-
ble between the ParkFit group and the control intervention (adjusted group difference 7%; 95% 
confi dence interval (CI), -3 to 17%; p=0.19). Analyses of three secondary outcomes indicated 
increased physical activity in ParkFit patients, as suggested by an activity diary (difference 30%; 
p<0.001), a tri-axial accelerometer (difference 12%; p<0.001), and the 6-minute walk test (dif-
ference 4.8 meters; p=0.05). Quality of life measured with the PDQ-39 did not differ between 
ParkFit and controls (difference -0.9 points; p=0.14). The number of fallers was comparable 
between both groups: ParkFit (62%) and controls (67%). 
 Compared with objective assessment of physical activity behavior in PD patients using a tri-axial ac-
celerometer, the screening questionnaire used in the ParkFit study showed to be sensitive to include 
sedentary patients. Whether this screening questionnaire is also sensitive to exclude patients who 
meet the recommendations for healthy physical activity, should be further investigated.
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CHAPTER 7 
EVALUATION OF THE PARKFIT PROGRAM
 The fi ndings of three secondary outcomes in the ParkFit study suggest increased activity (Chapter 
6); therefore, further implementation of the program could now be considered. To facilitate this 
potential implementation process, we evaluated our trial experience with the ParkFit program in 
three ways: (a) experiences of patients and physiotherapists, as investigated using interviews and 
questionnaires; (b) factors associated with changed activity levels; and (c) subgroup analyses to 
identify differential effects in subgroups of patients based on baseline physical activity level, age, 
gender, disease severity, disease duration, and mobility. 
 Data of 255 patients (85%) and 116 physiotherapists (97%) were collected. The ParkFit program 
was well received. Seventy-three percent of patients indicated they would recommend the pro-
gram to other patients, and 90% of physiotherapists indicated they wanted to use the ParkFit 
program in future patients. Less baseline physical activity and better mobility were associated 
with larger changes in physical activity over two years (R2=48%). The program was effective in 
almost all subgroups; the estimated effect size was largest in women, in patients who were most 
sedentary at baseline, and in patients with lower disease severity.  
 The ParkFit behavioral change program did not increase overall physical activity, as measured 
with the LAPAQ. The analysis of the secondary endpoints justifi es further work into the possible 
merits of behavioral change programs to increase physical activities in daily life.
 The ParkFit program was effective in almost all subgroups. Therapists and patients experi-
enced no major hurdles. This knowledge can be used for further implementation into everyday 
clinical practice.
09GENERAL DISCUSSION 
& FUTURE 
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PATIENTS WITH PD MOVE LESS
 We showed that patients with PD are less active compared to controls (Chapter 2). We additio-
nally observed that not all patients lead a sedentary lifestyle. Even some patients with advanced 
disease severity performed sport activities. This implies that a number of patients with PD in 
later stages of the disease are still able to perform (sport) activities. Since physical activity may 
improve specific symptoms of PD such as sleep impairment, depression, and constipation19, and 
because rodent work suggests that physical activity may counter neurodegeneration in experi-
mental parkinsonism76 84, this is an important message for patients as well as for clinicians. 
 The finding that not all PD patients are sedentary was confirmed during the inclusion procedure 
of the ParkFit study (Chapter 3). Out of the 3453 finally invited participants, about one third was 
physically sufficiently active according to international recommendations for healthy physical 
activity.15 16 21 165 However, since more than fifty percent in the healthy older population meets 
these recommendations, this difference between healthy adults and PD patients corroborates 
our previous results that patients are less active.  
THE CHALLENGE TO ASSESS PHYSICAL ACTIVITY
 Physical activity is a complex behavior. It includes sports as well as non-sports activities and 
it can be characterized by purpose (occupational or leisure), type (cycling, fitness or soccer), 
intensity (light, moderate or vigorous) and duration. The complexity of physical activity was 
also confirmed by the fact that  a lot of determinants are associated with this behavior, which 
were identified in different chapters of this thesis (Chapter 2, 4 and 5). The complex nature of 
physical activity behavior makes it also difficult to accurately measure all of its aspects. Various 
assessment methods have been used in research, both with advantages and disadvantages. 
The doubly labeled water method is the most accurate method to assess physical activity energy 
expenditure under free living conditions.68 However, this method is expensive and complex, and 
provides no information about which activities were performed.68 
 An alternative for objective assessment of levels of physical activity are ambulatory accelerome-
ters; these devices are feasible and increasingly recognized as valid and objective instruments 
for assessing free-living physical activity. However, their disadvantage is that they generally 
underestimate total energy expenditure of daily living: upper body movements, activities such 
as cycling, and static movements such as gardening or strength training are difficult to detect.68 171 
Pedometers offer an inexpensive alternative for objective ambulatory assessments, however, 
they are specifically designed to assess walking only. 
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 Self-report techniques are the most common measures of physical activity. Due to their subjec-
tive character, questionnaires as well as diaries might result in an under- or overestimation of 
physical activities.172 173 However, self-report techniques are feasible to assess habitual physical 
activity in large populations since they are practical and easy to administer, have relatively low 
costs and create low participant burden.156 171
 All methods described above have their shortcomings and advantages. In each situation, one 
has to choose the method(s) which is/are most appropriate given the specific circumstances, 
despite their shortcomings. Two examples are described below:
 The ParkFit program was designed to change behavior in sedentary patients. For the purpose 
of trial inclusion, physical activity levels of 3453 individuals had to be screened, so that we 
could include only the sedentary ones. Since objective assessment (for example with activity 
monitors or doubly labeled water) was impossible (i.e. not feasible), inclusion was based on a 
physical activity screening questionnaire (Chapter 3). To examine whether indeed only sedentary 
patients were included, daily physical activity behavior was subsequently measured with a tri-axial 
accelerometer (Chapter 5). The results showed that none (except for one) of the included met 
the international guidelines of daily physical activity; therefore, we concluded that the screening 
questionnaire was an appropriate tool to include sedentary PD patients. Despite the well known 
difficulties of measuring daily physical activity using questionnaires, it is important to know that 
this questionnaire was able to include the right patients. Whether this questionnaire is additionally 
able to exclude patients who did meet the recommendations for healthy physical activity, can only 
be investigated by assessments of all patients who were excluded based on their activity levels. 
 When we designed the ParkFit study, we had to choose the most appropriate instrument to as-
sess physical activity in daily life. We chose an interview-based physical activity questionnaire, 
the LAPAQ.55 The most important reason for this choice was the fact that the LAPAQ covers a 
wider range of activities compared to accelerometers. In addition, we chose two secondary 
measures to assess physical activity as well: a tri-axial accelerometer and a diary. As a conse-
quence, we were able to corroborate changes in physical activity detected with the LAPAQ using 
both an objective instrument and a subjective instrument. After 24 months, the overall LAPAQ 
did not change. However, both the activity monitor (+12%) and the diary (+30%) showed in-
creased physical activity. Stimulated by these positive findings, we re-examined the primary 
outcome using post hoc analyses. Specifically, the LAPAQ questionnaire reflects the net sum of 
‘outdoor and sport activities’ plus ‘household activities’. These post hoc analyses showed that 
a significant and possibly relevant (+24%) increase in outdoor and sport activities for ParkFit 
patients was offset by a concurrent decrease in household activities (-16%). 
 Although each instrument measures physical activities in a different way, the conclusions of the 
diary, accelerometer and post hoc analyses of the LAPAQ were comparable: patients in the 
ParkFit program increased their activity levels based on these outcome measures. Since the 
overall LAPAQ did not show differences in physical activity, while accelerometers, diaries and 
the post hoc analyses of the primary outcome did, we regard our decision to select overall physi-
cal activity as primary outcome as a shortcoming in the study design. It  seems that the total sum 
of outdoor and household activities obscure the changes in physical activity behavior. Further 
research should focus on comprehensive, valid and reliable instruments to accurately measure 
all of the aspects of physical activity behavior. Specifically in patients with chronic diseases since 
they generally perform (light and moderate) activities which are easy to overestimate when using 
questionnaires, and difficult to detect using accelerometers.
THE TWOFOLD CHALLENGE TO CHANGE BEHAVIOR
 In recent years, a number of physiotherapy programs have been tested in patients with PD.145-149 
Overall, these programs were generic (i.e. for each patient the same) and were delivered for 
a short period (2-10 weeks). Before and after the intervention period, patients were tested and 
basic characteristics such as strength, gait speed or balance improved (Figure 9.1). Furthermore, 
some reviews and two meta analyses were conducted on the effectiveness of physiotherapy and 
exercise interventions (under the umbrella of physiotherapy) in PD.25 77 150 151 152 Generally, they 
found evidence to support ‘exercise’ as being beneficial with regards to physical functioning, 
strength, balance and gait speed. Although these conditions might be important to be able to 
arrange an active lifestyle anyway, a physiotherapy program as tested in those studies is not suf-
ficient to achieve this lifestyle. In the knowledge that (1) patients with PD tend to lead a sedentary 
lifestyle; (2) the fact that some patients - even in more advanced stages - still perform activities; 
(3) the well known benefits of physical activity in general; and (4) the lack of a disease-specific 
physiotherapy program aiming to change sedentary behavior, we developed the ParkFit pro-
gram (Chapter 3). 
PHYSIOTHERAPISTS
 Before we could measure a behavioral change in patients, we first had to change the behavior 
of all participating physiotherapists (n=154). Physiotherapists had to be educated to ‘coach’ 
patients, rather than just treating them. Thus, the ParkFit study included a twofold challenge to 
change behavior. To change the behavior of physiotherapists, we took several steps. We first 
developed a specific handbook for physiotherapists, including information about the benefits 
and risks of physical activity, about the process of behavioral change, covering specific user 
information for the tools included in the ParkFit program, and a scheme to guide therapists 
through the coaching sessions. Second, we developed an educational workbook for patients 
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which included all elements of the ParkFit program. This workbook not only intended to inform 
patients, but also aimed to guide therapists in dealing with all specifi c elements that are impor-
tant for behavioral change. Third, physiotherapists were trained to treat patients in the ParkFit 
program during three educational sessions. Fourth, during the two-year intervention period, 
therapists could consult the research team at any time for advice. Moreover, the research team 
contacted therapists every three months by telephone to investigate whether they experienced 
any barriers in delivering the ParkFit program. Finally, after one year, an evaluation meeting with 
therapists was scheduled. These meetings aimed to refresh the knowledge of the various ParkFit 
elements and to discuss therapists’ experiences (Chapter 7). 
PATIENTS
 The primary analysis of the ParkFit study showed no signifi cant differences between ParkFit 
patients and controls after two years (Chapter 6); thus, no behavioral change was measured. 
However, the secondary outcomes (the activity monitor (+12%) and the diary (+30%)) showed in-
creased physical activity (and thus suggest a behavioral change) in ParkFit patients. As mentioned 
before, the LAPAQ yields a total sum score for outdoor and household activities, and we perfor-
med additionally post hoc analyses to investigate group differences for both types of activities. 
These post hoc analyses showed that the time spent on outdoor and sport activities increased in 
ParkFit patients (+24%) while the time spent on household activities decreased (-16%). 
FIGURE 9.1 
AIMS OF PHYSIOTHERAPY, (GROUP) EXERCISE AND PHYSICAL ACTIVITY PROMOTION IN PD
 Although it was a post hoc analysis, it is interesting to speculate about the observation that pa-
tients increased outdoor activities and decreased household activities. First, patients allocated 
to the ParkFit program might have spent more time to sport activities instead of household ac-
tivities. In other words, they could have shifted from indoor to outdoor activities. Second, since 
ParkFit patients performed more other (outdoor) activities, they might have underestimated the 
time spent on household activities. It is possible that they came to consider these activities as 
less important since they started to perform other, more strenuous activities. Both clarifi cations 
can be true, and might in fact co-exist. Since the aim of most behavioral change programs is 
to increase the time spent on outdoor and sport activities, and not to increase the time spent 
on household activities, we recommend future studies to use an instrument which is able to ca-
tegorize activities or even ignores household activities, for example our activity diary. Another 
possibility would be to split up the total LAPAQ scores into ‘household’ and ‘outdoor activities’. 
Otherwise, one might falsely conclude that participants did not change their behavior, while 
they possibly did.
 While statistically signifi cant, the increase in physical activities per week was not much in an 
absolute sense. Expressed in time units (based on the activity diary), ParkFit patients spent 
almost one and a half hour per week extra on outdoor and sport activities, compared to base-
line. Although not much, this increase was comparable with fi ndings in elderly populations and 
patients with other chronic conditions.158-161 For example, behavioral counseling for elderly in 
primary care yielded a one-hour increase in moderate-intensity physical activity.158 In addition, 
pedometer-based counseling programs increased total physical activity of cardiac patients by 
almost 1.5 hour/week.159 160 However, the long term follow-up sets the ParkFit study apart from 
these other studies. Specifi cally, follow-up periods in these earlier studies were only six months, 
while we followed our patients for two years. 
 Our results concerning adherence are comparable with previous short-term programs (up to 6 
months follow-up)168 169, but are remarkably higher compared with previous long-term programs 
(up to 14 months follow-up).170 In an exercise program of six months aiming to reduce fall risk in 
PD, 54% of patients completed at least 75% of the sessions.169 Another study of group exercise 
in PD found an attendance rate of 73% during 14 months.170 Several aspects of the ParkFit 
program could have contributed to its high adherence. First, the individually tailored character 
of the ParkFit program – with activities that participants enjoyed – makes participation more 
pleasant compared with exercise in general.165  Since patient and therapist jointly chose one or 
more (sport) activities, every patient was allowed to follow his or her own wishes, adjusted to 
the individual situation. Second, the disease-specifi c knowledge of the therapists could explain 
the high adherence. The intervention was delivered solely by experienced physiotherapists par-
ticipating in the Dutch ParkinsonNet.13 ParkinsonNet networks were specifi cally developed to 
improve the PD-specifi c expertise of health professionals, and to increase patient volumes per 
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therapists.13 Probably, due to these specific elements, therapists were able to adequately antici-
pate on perceived barriers of PD patients, and this could have improved patients’ adherence. 
 The different elements of the ParkFit program were offered as a ‘total package’ to achieve a be-
havioral change, and we evaluated the program likewise. Therefore, we cannot conclude which 
element of our multifaceted approach was the most successful (for example education, the ac-
tivity monitor, or the coach). However, the results of the evaluation questionnaire gave some in-
sight into the perceived success of all elements (Chapter 7). Specifically, therapists reported that 
they considered education and the coaching sessions as the most important tools of the ParkFit 
program. Most patients reported that the Activity Monitor was the most useful tool. Future work 
is needed to decide which component is most effective in increasing physical activity levels, and 
if any component of the ParkFit program will also be effective when it will be used in isolation. 
Another challenge would be to investigate physical activity levels after one or two more years. 
During the ParkFit study, patients were continuously coached by their physiotherapist. It will be 
interesting to find out whether patients will be able to maintain their levels of physical activity 
without supervision of their coach.
HEALTH BENEFITS RELATED TO PHYSICAL ACTIVITY
 The two other secondary outcomes (fitness and falls) aimed at finding possible health benefits 
related to the ParkFit program (Chapter 6). Physical fitness showed a small but significant dif-
ference in favour of ParkFit. Furthermore, we were concerned about possibly increased fall rates, 
because the amount of physical activity is associated with a greater risk of falling. However, the 
ParkFit program was not associated with more falls or injuries.
 We can speculate that the observed increase in physical activity measured with the secondary 
outcome measures may in turn lead to generic health benefits. For example, significant risk 
reductions of cardiovascular disease have been observed with 45 to 150 minutes per week of 
brisk walking.155 This suggests that the increase in physical activities observed in ParkFit patients 
based on the secondary outcomes might help to prevent development of cardiovascular disease 
in PD patients. This was not specifically studied in the present ParkFit trial, but should be a focus 
of future research.
 No differences were found for quality of life (secondary outcome) between both study arms 
(Chapter 6). We performed post hoc analyses for the complete battery of tertiary outcome 
measures to investigate the relationship between physical activity and specific health benefits 
(for example mobility, sleep and depression; all outcome measures were described in Chapter 
3). Small but significant correlations were found between the change in level of physical activity 
and changes in mobility, quality of life, and disease severity: the subgroup of patients with the 
greatest increase in physical activity also showed better quality of life, lower disease severity 
scores and relatively greater mobility. These findings support the hypothesis that physical activity 
is accompanied by health benefits. However, the results have to be interpreted with caution since 
the direction of these relations is unclear; for example, patients with only minimal changes in 
disease severity could have been able to increase physical activity more easily. 
 The lack of evidence for other health benefits in the ParkFit study could possibly be explained by 
several reasons. 
 First, it is possible that there is no relationship between (increased) physical activity and health. 
However, this seems unlikely, since many studies have shown beneficial effects of (increased) 
regular physical activity.14 15 165 
 Second, the intensity of the performed activities might have been too low. We showed that 
ParkFit patients were able to increase their time spent on outdoor and sport activities, but the 
increase in time may not have been enough to achieve tangible health effects (apart from the 
improved physical fitness, which did occur in the ParkFit group). This hypothesis is in accordance 
with an earlier study which concluded that intensity, and not duration, of physical activities is 
related to improvements in cognitive function.174 Since the ParkFit program was individually tail-
ored and every patient was allowed to choose his or her own ‘activity’, patients selected mainly 
activities such as walking or fitness. We cannot exclude that greater health benefits might have 
been achieved when the one hour increase had been spent on more vigorous physical activity 
such as running. To determine whether a higher intensity of physical activity will translate into 
clinically relevant health improvements, more work remains necessary. The same applies to 
specific type and duration of activities. We are now performing a new exercise study where 
patients are instructed to participate in fairly intensive cycling activities for five times a week (the 
ParkCycle study). In addition, we participate in a large European multicenter study which studies 
the combined effects of treadmill walking plus a complex three-dimensional stimulation that 
necessitates gait adaptations (the V-time study).131
 Third, our choice for the control intervention might have obscured larger differences between 
the ParkFit patients and controls. Specifically, we elected to refer patients in the control arm to 
a physiotherapist who aimed to improve the safety of movements, but without emphasizing the 
volume of physical activities. This approach helped to maintain blinding of patients with respect 
to treatment allocation. Indeed, debriefing of patients confirmed that patients were unaware of 
treatment allocation, and patients in both arms felt they had received an ‘active’ intervention. A 
strong element of our study was the careful matching of treatment intensity between both study 
arms. An additional reason for having a physiotherapy program as control intervention was that 
we felt that abstaining control patients from physiotherapy for two years was unethical. Certainly, 
having a control group without any physiotherapy might have helped to create maximal contrast 
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between both study arms. However, the ParkFit study took place in ‘the real world’ and phy-
siotherapy in PD is ‘usual care’, certainly in the Netherlands where at least 60% of PD patients 
receives physiotherapy annually.7  We therefore considered a control group with physiotherapy 
as the most meaningful design.
 Finally, new perspectives in the literature propose that ‘too much sitting’ is different from ‘too 
little exercise’.175-177 Chronic unbroken periods of muscular unloading associated with prolonged 
sedentary time may have deleterious biological consequences.178 In the ParkFit study, sitting time 
was not measured. As a consequence, we cannot conclude whether time spent on prolonged 
periods of sitting was changed during the intervention period. Whether this could be a clarifi -
cation for the lack differences between both groups, should be investigated in further studies by 
measuring prolonged sitting periods as well. 
EXTRAPOLATION AND IMPLEMENTATION OF THE 
PARKFIT PROGRAM 
 The ParkFit study showed that a multifaceted behavioural change program does not promo-
te overall physical activities in sedentary PD patients, as measured with the primary outcome 
(LAPAQ). Two of our secondary outcomes focused on other measures of physical activity, and 
did suggest improvements for patients allocated to the ParkFit program. This was demonstrated 
both subjectively (with activity diaries) and objectively (with an ambulatory activity monitor). 
Moreover, physical fi tness (an indirect refl ection of greater physical activity) increased in ParkFit 
patients.
 Since our participants were on average less sedentary compared to patients who declined to 
participate, it remains unclear whether the effects can be generalized to more sedentary pa-
tients. The same applies to patients with severe apathy, severe cognitive impairment or depres-
sion since these were not included in the ParkFit study. As physiotherapists reported that patients 
with relatively mild cognitive impairments were more diffi cult to coach (Chapter 7), it is relevant 
to further investigate how these patients can best be stimulate to become more active.
 The ParkFit program was now offered solely by physiotherapists with PD-specifi c expertise, which 
likely helped to overcome any barriers imposed by the physical and mental limitations of PD pa-
tients. The question is whether adding professionals from other disciplines might help to further 
improve the quality of the behavioral change program. One suggestion that was raised during the 
debriefi ng interviews was to add a psychologist, who could address the cognitive issues associated 
with PD, but who also adds specifi c expertise about behavioral change. One could also consider 
adding sport instructors, since they have specifi c knowledge about coaching, counseling, sports 
and exercise (Figure 9.1). It will be interesting to examine the possible role of such sport instructors 
within an upgraded version of the ParkFit program. For example, we anticipate that patients with 
greater disease severity will require more specifi c knowledge of a specialized physiotherapist, 
while patients in earlier stages could be coached solely by a sport instructor (Chapter 7).
 Irrespective of which healthcare professional(s) deliver(s) the ParkFit program, education of 
these providers is an important prerequisite. Aspects such as self-effi cacy and outcome expec-
tations are key elements for behavior and thus for behavioral change.33 To be able to optimally 
offer such a behavioral change program, providers have to be educated in these principles and 
in the specifi c strategies which can be used to coach people towards a more active lifestyle. 
 In conclusion, patients with PD are less active compared to controls. Reversing this sedentary 
lifestyle could have various benefi ts. Therefore, we developed a multifaceted intervention pro-
gram aiming to increase physical activity in patients with PD. The ParkFit behavioral change 
program did not increase overall physical activity, as measured with the LAPAQ. The analysis 
of the secondary endpoints suggest possible merits of behavioral change programs to increase 
physical activities in daily life in patients with PD. These fi ndings implies the ParkFit intervention 
as a meaningful supplement in the care of PD, although more work remains needed to further 
optimize the intervention and to investigate the effects. 
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HOOFDSTUK 2 
FYSIEKE INACTIVITEIT BIJ MENSEN MET DE ZIEKTE VAN 
PARKINSON
 Van mensen met de Ziekte van Parkinson wordt verondersteld dat ze vanwege hun fysieke, cog-
nitieve en emotionele beperkingen inactief zijn. Desondanks zijn er maar een paar studies die dit 
hebben onderzocht en de resultaten waren inconsistent. In Hoofdstuk 2 onderzoeken we deze 
veronderstelling door het niveau van fysieke activiteit van mensen met de Ziekte van Parkinson 
te vergelijken met controles. We hebben hiervoor een gevalideerde vragenlijst gebruikt (LASA 
Physical Activity Questionnaire, LAPAQ). 
 De studie laat zien dat patiënten inderdaad minder actief zijn dan mensen zonder de ziekte 
van Parkinson: we vonden een verschil van 29% in hun dagelijks activiteitenniveau (95% be-
trouwbaarheidsinterval 10 tot 44%). Dit verschil was het duidelijkst bij mensen met een hogere 
ziekte-ernst. Daarnaast hebben we gekeken naar ziektegerelateerde factoren die het niveau 
van fysieke activiteit bij mensen met de ziekte van Parkinson beïnvloeden. Multivariate regressie 
analyses lieten zien dat hogere ziekte-ernst, loopproblemen en meer beperkingen in het dage-
lijks leven een negatieve invloed hadden op het activiteitenniveau (R2=24%).
HOOFDSTUK 3
DESIGN VAN EEN GERANDOMISEERDE GECONTROLEERDE 
STUDIE OM MENSEN MET DE ZIEKTE VAN PARKINSON 
TE STIMULEREN TOT MEER FYSIEKE ACTIVITEIT
 Regelmatige fysieke activiteit vermindert het risico op chronische ziekten zoals hart- en vaatziekten, 
diabetes mellitus type 2, osteoporose en obesitas. Tevens zou fysieke activiteit invloed kunnen heb-
ben op de klinische symptomen van de ziekte van Parkinson en zelfs het verloop van de ziekte po-
sitief kunnen beïnvloeden. Echter, een inactieve levensstijl veranderen is moeilijk; het verhogen van 
fysieke activiteit bij ouderen of bij mensen met een chronische ziekte is mogelijk nog moeilijker. Wij 
hebben een interventie programma ontwikkeld om inactieve mensen met de ziekte van Parkinson te 
stimuleren tot meer fysieke activiteit (het ParkFit programma). Om het effect van het programma te 
onderzoeken, wordt in een gerandomiseerde gecontroleerde studie het ParkFit programma vergele-
ken met reguliere fysiotherapie conform de KNGF Richtlijn Ziekte van Parkinson.
 Het ParkFit programma is enerzijds gebaseerd op theorieën en modellen over gedragsverandering, 
 Mensen met de ziekte van Parkinson zijn bijna een derde minder actief dan mensen zonder de 
ziekte. De mate van ziekte ernst, loopproblemen en beperkingen in het dagelijks leven zijn fac-
toren die een rol spelen bij deze inactieve  leefstijl. 
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en anderzijds bevat het frequent gebruikte gedragsveranderingtechnieken die effectief blijken te 
zijn. De belangrijke elementen van het programma zijn: (a) de fysiotherapeut fungeert als coach 
die gedurende maandelijkse coachsessies de patiënt begeleidt naar een actieve leefstijl; (b) een 
handboek met informatie over bewegen, de voordelen van sporten en bewegen, en geschikte 
activiteiten voor mensen met de ziekte van Parkinson; (c) het in kaart brengen en overwinnen van 
barrières ten aanzien van bewegen; (d) het systematisch stellen van doelen middels een gezond-
heidscontract tussen coach en patiënt, en een logboek; (e) het stimuleren om deel te nemen aan 
groepssessies om te ervaren hoe het is om te bewegen en om stimulans van andere patiënten te 
ervaren; en (f) een activiteitenmonitor die registreert en feedback geeft over het dagelijks activitei-
tenniveau. Hoofdstuk 3 beschrijft het ParkFit programma en het design van de ParkFit studie. De 
primaire uitkomst van het onderzoek is de verandering in fysieke activiteit gedurende twee jaar, 
gemeten met de LAPAQ, een gestructureerde vragenlijst die vraagt naar dagelijkse activiteiten 
over de afgelopen week. Daarnaast wordt onderzocht in hoeverre bewegen voordelen dan wel 
nadelen heeft voor deze specifi eke patiëntengroep. 
HOOFDSTUK 4 
MULTIVARIABELE ANALYSES HEBBEN VAAK
MEERDERE OPLOSSINGEN: EEN VOORBEELD
 In Hoofdstuk 2 hebben we middels multivariate analyse gezocht naar determinanten van fysieke 
activiteit bij mensen met de ziekte van Parkinson. We vonden in eerste instantie een model met 
vier variabelen die het niveau van fysieke activiteit (mede) konden verklaren: geslacht, aanwezig-
heid van andere ziekten, de mobiliteit en beperkingen in het dagelijks leven. Dit model verklaarde 
22% van de variatie in fysieke activiteit bij mensen met Parkinson. Ondanks dat de verklaarde 
variantie slechts 22% was, bleken andere variabelen geen toegevoegde waarde te hebben;  alle 
variabelen samen verklaarden slechts 24% van de variatie in fysieke activiteit bij deze groep. In 
Hoofdstuk 4 laten we aan de hand van dezelfde data zien dat er meerdere opties zijn om die 
relatie te ‘beschrijven’ en concluderen we dat er geen sprake is van één juiste oplossing.
 De ParkFit studie toetst een nieuw interventie programma met als doel een gedragsverandering 
te bewerkstelligen bij inactieve mensen met de ziekte van Parkinson. Met deze studie worden 
gedragsveranderingsmodellen en -technieken voor het eerst toegepast bij mensen met de ziekte 
van Parkinson.
HOOFDSTUK 5 
KWANTIFICEREN VAN HET NIVEAU VAN INACTIVITEIT 
EN HET IDENTIFICEREN VAN DE MOGELIJKE DETERMI-
NANTEN BIJ MENSEN MET DE ZIEKTE VAN PARKINSON 
Vragenlijsten worden in grote populaties veelvuldig gebruikt om fysieke activiteit te meten. Echter, 
resultaten kunnen een onder- of een overschatting zijn vanwege het subjectieve karakter van 
deze instrumenten. Binnen de ParkFit studie werden alleen inactieve patiënten geïncludeerd, 
gebaseerd op een screeningsvragenlijst over fysieke activiteit. De vraag is in hoeverre deze 
patiënten ook middels een objectief meetinstrument geclassifi ceerd zouden worden als zijnde 
inactief. Om dit vast te stellen werd het niveau van fysieke activiteit van alle deelnemers aan de 
ParkFit studie objectief gemeten met behulp van een activiteitenmonitor. Fysieke activiteit werd 
gemeten met een drie-assige activiteitenmonitor die om de nek, in de broekzak of aan de riem 
gedragen kan worden. Aanvullend werden de determinanten van fysieke activiteit bepaald.
 In totaal hadden 467 patiënten (80%) een valide meting over minimaal zeven opeenvolgende 
dagen. De mediaan van het totale energieverbruik was 464 kilocalorieën per dag en gemiddeld 
waren patiënten 12 minuten per dag matig tot intensief actief. Niemand van hen, behalve  één, 
haalde de Nederlandse Norm voor Gezond Bewegen die stelt dat mensen op minimaal vijf da-
gen per week 30 minuten (in blokken van tien aaneengesloten minuten) matig tot intensief actief 
moeten zijn. Een hogere leeftijd, het vrouwelijk geslacht, een lagere fi theid en meer motorische 
problemen waren gerelateerd aan een lager niveau van fysieke activiteit (R2=0.69; p<0.001). 
 Vergeleken met het objectief meten van beweeggedrag bij mensen met de ziekte van Parkinson 
middels een activiteitenmonitor, blijkt de screeningsvragenlijst uit de ParkFit studie geschikt om 
inactieve patiënten te identifi ceren. In hoeverre dit instrument ook geschikt is om mensen die 
wel voldoen aan de Nederlandse Norm Gezond Bewegen te identifi ceren moet verder worden 
onderzocht.
 Meerdere modellen blijken geschikt om de relatie tussen de afhankelijke variabelen en het 
niveau van fysieke activiteit bij mensen met de ziekte van Parkinson te beschrijven. Als het doel 
van een studie is om determinanten te identifi ceren die zijn geassocieerd met een bepaalde 
uitkomst, is het dus aan te bevelen om zowel het uiteindelijke model als modellen met een ver-
gelijkbare ‘fi t’ te presenteren. 
promotion of physical activity in parkinson's disease • the challenge to change behavior
128 129
nederlandse samenvatting 1010
HOOFDSTUK 6 
RESULTATEN VAN DE PARKFIT STUDIE
 De resultaten van de ParkFit studie laten zien dat de tijd die besteed werd aan fysieke activiteit 
niet verschilde tussen de ParkFit groep en controles (verschil: 7%; 95% betrouwbaarheidsinterval -3 
tot 17%; p=0.19). Analyses van de secundaire uitkomstmaten lieten echter wel een toename zien 
van fysieke activiteit bij patiënten die het ParkFit programma hadden gevolgd. Zowel op basis van 
het beweegdagboek (verschil van 30%; p<0.001), als op de activiteitenmonitor (verschil van 12%; 
p<0.001), als op de 6 minuten wandeltest (verschil van 4.8 meter; p=0.05) waren patiënten in 
ParkFit signifi cant verbeterd ten opzichte van controles. Kwaliteit van leven gemeten met de PDQ-39 
verschilde niet tussen beide groepen (verschil van -0.9 punten; p=0.14). Het aantal mensen dat één 
of meerdere keren viel, was vergelijkbaar tussen de ParkFit groep (62%) en de controlegroep (67%).
HOOFDSTUK 7
EVALUATIE VAN HET PARKFIT PROGRAMMA
 Drie secundaire uitkomstmaten van de ParkFit studie laten een toename van fysieke activiteit 
zien (Chapter 6);  derhalve zou verdere implementatie van het programma zinvol kunnen zijn. 
Om het implementatieproces te faciliteren, werd de ParkFit studie op verschillende wijzen ge-
evalueerd: (a) ervaringen van patiënten en therapeuten middels interviews en vragenlijsten; (b) 
inventarisatie van factoren die geassocieerd waren met veranderd niveau van fysieke activiteit; 
en (c) analyses om effecten in verschillende subgroepen van patiënten te inventariseren; de 
indeling in subgroepen was gebaseerd op de volgende variabelen: niveau van fysieke activiteit 
op baseline; leeftijd; geslacht; ziekte ernst; ziekteduur; en mobiliteit van de patiënt.
Data van 255 patiënten (85%) en 116 fysiotherapeuten (97%) liet zien dat zij over het algemeen 
heel tevreden waren over programma: 73% van de patiënten gaf aan dat zij het zouden aanbe-
velen aan andere patiënten, en 90% van de therapeuten zou het programma in de toekomst bij 
andere patiënten toepassen. Een lager niveau van fysieke activiteit op baseline en een hoger ni-
veau van mobiliteit waren geassocieerd met een hogere toename van fysieke activiteit over een 
periode van twee jaar (R2=48%). Het ParkFit programma was effectief in nagenoeg alle sub-
groepen; patiënten die hun activiteitenniveau het meest verbeterden, waren vrouwen, patiënten 
met een lager niveau van fysieke activiteit op baseline, en patiënten met een lagere ziekte ernst. 
 Het ParkFit programma had geen invloed op het niveau van fysieke activiteit van mensen met de 
ziekte van Parkinson, gemeten met de LAPAQ. Echter, de resultaten van de secundaire uitkomst-
maten lijken een toename in het activiteitenniveau te suggereren waardoor verder onderzoek 
naar de voordelen van gedragsveranderingsprogramma’s zinvol is.
 
 Als gevolg van het ParkFit programma verhoogde het niveau van fysieke activiteit in bijna alle 
subgroepen van patiënten. Zowel therapeuten als patiënten hebben geen grote belemmeringen 
ervaren voor verdere implementatie. 
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